Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430770-177442503	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 32.2;Karpas-707: 45.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"	NA	NA		28000000			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (8.61e-4)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	12.8	15.1	11.2	11.2	11.9	10.9	18.5	4.4	13.7	13.5	12.1	24.2	8.0	8.0	9.8	26.4	18.8	7.1	15.1	8.4	13.0	9.4	20.5	26.5	12.4	12.3	14.0	11.0	10.2	14.7	19.2	9.0	9.3	15.0	10.1	11.1	24.0	27.1	10.8	6.7	16.9	14.4	8.1	22.3	14.9	13.0	13.3	10.0	13.4	14.0	14.3	18.3	9.0	10.2	10.0	11.1	16.3	23.8	8.9	16.3	10.3	2.1	4.7	5.4	7.7	6.4	5.7	3.7	15.8	32.2	8.2	10.4	2.5	10.6	10.5	2.9	12.2	4.0	2.6	4.6	5.2	16.7	6.8	3.0	4.4	5.2	6.9	4.2	7.6	3.0	4.0	9.1	6.0	2.7	7.4	7.7	4.7	3.9	45.6	3.3	5.8	6.1	4.8	2.1	4.2	4.9	1.9	2.2	1.6	8.7	5.3	3.0	6.9	4.7	4.1	12.5	4.3	9.3	15.7	2.4	5.7	5.1	2.7	6.1	8.8	6.7	5.6	9.2	8.7	6.4	15.0	10.7	16.3	11.7	18.9	13.4	10.0	12.8	14.0	10.5	8.1	11.4	16.3	2.4	8.9	23.8	11.1	12.0	10.3	11.2	11.9	4.4	13.7	13.0	9.4	14.0	11.0	15.0	10.0	11.9	9.1	12.3	14.9	21.3	3.3	5.7	17.8	5.3	11.4	14.0	2.0	21.6	5.0	21.9	11.4	11.1	9.1	0.0	27.5	25.3	15.5	15.7	13.9	15.1	21.7	6.4	5.2	6.2	9.1	6.8	10.3	22.8	37.1	25.2	16.6	17.6	20.6	5.8	9.2	16.3	3.7	0.0	12.4	34.8	31.5	23.8	19.0	22.3	13.4	15.2
ALG1	"CDG1K, HMAT1, HMT-1, Mat-1"	ENSG00000033011	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase"	Q9BT22	16	5033960-5087379	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA060392	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.66e-2)"	"unprognostic (5.18e-1)"	"prognostic favorable (5.79e-4)"	"unprognostic (1.55e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.58e-3)"	"unprognostic (3.86e-2)"	11.0	22.2	8.7	10.8	12.8	6.6	12.8	9.3	18.8	13.7	16.4	14.9	10.1	14.7	12.1	17.0	11.7	12.4	14.3	8.1	8.8	10.4	18.9	31.6	9.9	12.7	10.5	6.5	10.1	27.9	21.5	13.6	10.7	14.6	10.8	17.2	15.5	20.6	12.0	7.3	9.1	12.8	12.1	9.4	16.2	16.5	19.4	11.4	16.0	15.0	8.7	14.5	12.1	8.7	20.7	24.3	7.8	23.3	20.9	26.5	31.7	6.5	17.8	4.5	8.4	17.2	10.3	8.3	14.7	20.7	19.2	19.3	14.7	24.2	13.9	12.7	18.7	8.0	17.6	12.3	14.5	13.1	11.4	13.9	7.8	14.8	30.3	14.1	13.6	13.7	12.4	11.0	15.1	9.6	7.6	11.4	11.3	9.7	18.2	14.2	17.7	8.7	16.7	17.0	11.9	10.2	16.2	6.2	38.7	12.0	7.1	7.6	7.7	15.7	24.6	8.4	6.3	16.0	11.1	10.9	9.0	8.3	45.5	12.3	13.3	16.0	9.4	7.4	14.6	12.7	3.3	23.3	7.8	26.5	21.6	23.1	19.8	22.9	25.4	24.3	20.7	21.0	23.7	1.5	20.9	21.2	21.2	21.6	31.7	8.7	12.8	9.3	18.8	8.8	10.4	10.5	6.5	14.6	11.4	14.9	6.7	14.0	2.8	2.2	7.1	0.6	12.7	12.0	7.9	7.0	11.8	13.9	3.3	15.9	8.2	4.5	8.4	0.0	24.6	16.8	7.2	3.4	1.1	15.5	19.6	3.2	12.9	9.2	8.2	23.0	8.9	5.9	10.1	6.4	17.7	7.2	18.4	10.5	6.3	8.7	5.0	6.5	1.4	25.9	17.2	1.4	7.1	8.7	18.0	3.5
ALG10	"ALG10A, DIE2, FLJ14751"	ENSG00000139133	"ALG10, alpha-1,2-glucosyltransferase"	Q5BKT4	12	34022281-34029694	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.88e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.29e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.45e-2)"	6.2	7.0	2.7	5.4	5.9	6.9	6.9	4.0	5.5	5.3	4.6	3.8	3.6	3.4	10.3	5.5	6.0	6.2	3.7	4.6	2.6	2.9	4.6	5.7	5.4	6.7	4.1	1.7	7.1	7.8	7.5	6.1	7.2	3.5	5.8	4.1	8.7	9.0	4.4	4.6	5.1	5.0	4.0	3.5	6.1	5.1	8.0	3.6	17.2	6.2	3.0	9.8	5.8	4.8	2.7	1.8	4.5	2.7	2.1	3.8	1.6	4.5	5.4	3.5	5.8	4.2	3.3	12.4	4.4	4.1	4.8	8.6	7.9	11.0	6.9	6.5	2.2	7.1	6.9	6.6	5.6	6.5	11.0	6.3	6.4	5.7	3.1	1.7	9.2	6.7	3.6	3.3	10.1	7.7	2.3	3.2	6.2	9.6	11.7	3.9	6.2	5.9	5.1	13.1	2.7	6.8	5.3	12.7	7.0	2.6	6.8	3.1	2.5	7.7	3.3	5.5	10.5	7.9	2.5	6.8	6.6	9.8	8.8	5.5	6.4	11.5	13.3	4.6	3.7	5.2	0.0	2.7	4.5	1.9	1.2	3.0	2.5	2.6	1.1	1.8	2.7	3.1	3.8	0.4	2.1	1.2	1.8	3.0	1.6	2.7	5.9	4.0	5.5	2.6	2.9	4.1	1.7	3.5	3.6	6.0	0.3	3.0	2.5	1.3	3.5	0.8	2.5	4.0	3.4	5.2	3.9	6.4	1.7	1.9	0.6	2.1	1.0	0.0	3.3	4.7	2.1	0.6	1.1	2.4	2.9	1.6	1.2	0.6	2.7	0.0	1.4	2.1	0.0	4.6	1.9	3.7	2.6	0.0	1.1	1.1	4.1	0.0	1.0	7.5	3.0	2.4	2.6	4.3	1.7	1.4
ALG10B	KCR1	ENSG00000175548	"ALG10B, alpha-1,2-glucosyltransferase"	Q5I7T1	12	38316578-38329728	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (4.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.43e-2)"	"unprognostic (8.58e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	8.2	8.5	4.3	4.9	7.0	6.6	9.1	5.3	7.2	6.1	4.4	5.4	9.5	4.2	8.5	6.7	6.9	6.4	6.0	5.8	5.0	2.7	5.9	6.6	6.5	7.3	6.6	4.8	8.7	9.6	8.7	7.8	11.6	4.3	6.1	4.5	10.5	9.3	9.7	5.8	7.7	6.5	4.6	4.5	7.5	6.4	8.9	5.0	10.5	7.4	5.6	6.6	7.7	6.8	3.6	2.6	2.0	2.0	1.4	4.1	1.2	5.0	4.7	6.2	6.2	3.1	5.8	6.4	4.0	2.1	5.4	4.8	1.7	15.3	7.7	7.0	2.0	4.0	5.3	5.4	4.4	7.8	5.1	6.9	8.1	8.1	3.4	3.4	10.8	5.7	3.2	5.8	7.6	5.6	4.8	3.9	9.8	9.1	4.7	4.5	3.8	7.2	8.6	7.8	0.5	4.7	2.4	13.3	6.1	4.6	6.3	1.8	6.4	7.0	2.4	4.8	6.9	10.7	4.4	3.3	5.7	6.6	5.0	5.0	3.7	9.5	12.3	4.8	7.6	7.1	1.2	1.5	2.0	1.1	2.0	2.2	1.8	1.1	1.8	1.1	3.6	2.2	2.7	0.6	1.4	1.4	2.6	4.1	1.2	4.3	7.0	5.3	7.2	5.0	2.7	6.6	4.8	4.3	5.0	6.0	11.5	0.5	3.5	1.8	12.9	3.0	0.0	6.7	9.1	3.5	31.4	15.2	6.6	3.6	0.2	4.9	1.2	0.0	5.0	8.2	3.5	2.4	1.1	5.9	4.2	9.5	0.0	6.2	1.5	1.5	3.7	1.9	1.7	0.0	2.5	8.9	3.5	2.0	5.3	2.2	12.4	6.5	1.4	8.3	3.4	1.6	6.8	1.3	2.5	2.3
ALG11	"CDG1P, KIAA0266"	ENSG00000253710	"ALG11, alpha-1,2-mannosyltransferase"	Q2TAA5	13	52012398-52029664	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 17.9;Ciliated cells: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047214	Approved					NA	NA					"HPA047214: AB_10961640"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.97e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.71e-3)"	14.7	16.9	11.9	9.6	16.2	14.2	13.8	11.8	17.7	13.9	11.9	12.6	15.9	9.8	15.2	13.0	12.6	12.9	11.3	12.2	13.4	9.5	17.3	20.9	11.5	9.3	13.5	11.5	13.1	15.6	18.4	18.4	19.5	15.7	13.5	13.9	11.4	17.6	13.7	13.0	13.7	15.6	14.2	16.6	11.6	13.1	12.2	12.3	13.8	19.6	7.0	10.3	14.7	11.2	10.4	14.4	14.6	14.1	8.7	13.3	6.4	5.0	7.1	12.3	12.2	11.1	10.9	10.8	13.5	11.4	10.4	9.0	9.5	12.3	10.0	3.7	11.6	10.8	10.7	12.7	8.9	14.2	11.8	9.6	23.9	7.6	8.6	10.7	20.0	24.0	10.0	13.4	9.6	11.4	8.6	9.3	11.5	13.6	9.8	12.6	4.5	9.7	7.4	12.7	15.7	5.9	12.6	8.9	6.1	10.3	9.9	5.2	9.6	10.3	9.6	8.4	10.3	11.7	11.7	13.2	9.6	7.8	9.8	9.8	5.5	7.7	13.2	6.3	7.6	15.8	14.6	7.4	9.8	11.3	6.0	11.2	8.0	10.2	10.5	8.3	10.4	13.1	13.3	4.1	8.7	14.1	14.4	9.8	6.4	11.9	16.2	11.8	17.7	13.4	9.5	13.5	11.5	15.7	12.3	17.9	5.1	1.5	2.3	2.2	5.8	5.5	5.1	17.4	10.3	3.5	5.9	3.0	1.7	2.4	0.7	3.5	2.5	0.0	2.0	2.6	2.2	2.1	3.5	3.0	2.2	4.8	2.9	7.4	2.1	0.2	3.1	3.3	1.7	1.0	1.8	3.6	2.2	1.7	1.1	1.1	6.7	0.0	1.4	4.2	3.3	2.0	4.0	3.1	1.7	3.3
ALG12	"CDG1G, ECM39"	ENSG00000182858	"ALG12, alpha-1,6-mannosyltransferase"	Q9BV10	22	49900229-49918458	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003076, HPA051665"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003076: AB_2666777, HPA051665: AB_2681566"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.39e-3)"	"prognostic favorable (6.09e-4)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.60e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.32e-2)"	9.8	13.3	9.6	11.3	11.2	8.5	9.9	16.0	12.7	10.9	11.7	16.2	15.7	18.0	13.2	11.5	12.1	11.4	11.0	12.0	10.0	5.8	14.1	22.8	10.8	9.2	11.6	7.9	11.8	17.5	14.7	10.6	11.3	10.9	13.5	7.1	12.2	19.4	10.2	8.7	11.5	14.8	7.7	8.9	11.5	14.5	6.5	14.9	12.6	24.5	10.5	12.8	12.1	10.3	7.6	7.8	17.7	9.4	16.1	12.7	7.9	7.0	7.1	7.5	12.5	14.5	6.8	8.4	7.4	6.7	8.8	7.1	11.6	10.2	3.8	6.8	6.6	9.6	12.9	9.2	8.8	4.4	6.0	13.5	3.5	11.9	11.7	16.4	8.7	7.7	10.2	9.1	8.6	12.4	9.7	8.4	8.7	4.3	9.6	4.6	16.1	8.4	7.1	7.2	9.4	6.6	14.2	9.5	10.0	9.2	8.1	5.1	8.4	11.8	22.5	9.2	10.6	9.2	7.8	6.5	9.8	7.5	6.8	5.6	8.5	3.9	5.0	10.9	6.7	9.3	17.7	8.8	7.4	12.4	8.2	12.7	5.3	9.8	12.2	7.7	7.6	8.3	9.3	6.9	16.1	9.4	7.8	12.3	7.9	9.6	11.2	16.0	12.7	10.0	5.8	11.6	7.9	10.9	14.9	8.9	1.9	8.1	9.0	3.7	5.4	1.2	2.5	5.3	7.9	17.4	2.0	17.2	3.3	14.4	4.7	6.9	15.5	0.0	11.7	19.0	7.8	8.8	8.1	11.9	15.8	3.2	6.4	7.4	8.6	3.0	8.1	6.1	10.1	10.8	11.2	3.4	10.1	7.0	7.8	5.5	5.1	0.0	3.3	8.6	9.4	5.3	22.0	12.9	13.7	8.1
ALG13	"CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W"	ENSG00000101901	"ALG13, UDP-N-acetylglucosaminyltransferase subunit"	Q9NP73	X	111665811-111760649	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002853, HPA005498"	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA002853: AB_1078131, HPA005498: "	"unprognostic (4.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.97e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.62e-3)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.45e-2)"	20.6	23.0	18.4	23.2	23.2	19.3	24.8	20.9	25.5	21.1	23.3	21.6	22.0	18.0	26.3	28.5	18.3	22.5	22.2	16.8	16.6	16.2	23.5	31.1	19.7	28.4	22.4	16.1	24.2	18.8	13.0	41.7	18.7	19.5	26.7	26.5	16.3	19.5	25.6	11.2	25.2	25.7	23.5	21.6	31.4	20.1	19.0	20.3	23.6	24.5	14.6	25.8	18.3	20.9	10.2	14.4	21.7	12.5	3.4	11.1	7.1	10.9	12.4	11.1	7.0	7.2	10.4	6.3	8.9	9.2	11.5	14.3	12.4	11.5	9.5	17.1	12.3	23.8	6.3	13.2	6.3	12.1	6.8	8.8	5.2	14.0	14.1	10.7	9.5	21.0	12.3	11.8	9.2	20.0	12.0	12.5	10.9	11.6	27.4	11.4	27.8	8.0	8.6	10.2	32.8	17.0	6.2	7.1	13.2	18.3	16.9	6.7	9.8	12.7	7.7	7.7	11.6	6.9	9.2	8.4	9.9	4.9	12.8	17.0	13.2	21.9	15.3	10.6	12.6	7.5	21.7	12.4	12.2	7.8	12.5	7.6	8.4	8.9	7.6	14.4	10.2	11.1	9.1	2.5	3.4	9.4	7.5	10.7	7.1	18.4	23.2	20.9	25.5	16.6	16.2	22.4	16.1	19.5	20.3	14.9	31.5	32.3	54.9	31.3	12.7	15.1	20.4	34.8	25.0	17.4	9.8	22.8	38.1	27.8	14.0	38.3	32.8	0.0	45.1	32.1	22.1	46.9	109.4	26.7	37.3	11.1	25.4	23.4	36.4	6.8	19.8	44.5	27.0	35.1	42.8	12.8	44.6	41.2	15.2	44.0	14.8	25.8	39.0	9.9	16.3	30.9	40.7	34.5	28.5	55.9
ALG14	MGC19780	ENSG00000172339	"ALG14, UDP-N-acetylglucosaminyltransferase subunit"	Q96F25	1	94974407-95072945	"Disease related genes, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031829	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA031829: AB_2674062"	"unprognostic (7.79e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.93e-1)"	5.8	13.2	6.8	4.1	8.5	4.6	6.8	5.6	8.0	5.5	7.5	8.5	7.0	8.5	5.4	11.3	5.7	4.8	6.1	6.3	7.0	7.2	8.9	15.1	5.3	7.5	8.2	4.7	5.3	12.6	5.8	6.6	6.3	8.4	5.1	8.7	6.9	14.5	9.8	7.2	5.0	9.2	4.4	9.4	5.8	6.0	10.0	4.2	3.7	8.5	6.2	5.3	4.8	4.2	4.9	5.8	3.1	3.9	2.8	3.8	1.9	5.2	3.3	2.8	2.5	2.2	3.8	2.5	3.8	4.1	3.9	3.3	3.9	1.8	2.7	4.0	4.7	4.7	3.6	3.2	3.6	4.7	5.7	5.5	1.5	3.6	5.9	3.6	3.6	1.0	4.1	3.7	2.9	2.9	3.2	3.3	3.6	2.9	3.6	3.7	2.5	3.8	2.3	1.7	5.2	4.8	2.4	5.7	2.9	4.4	3.0	2.5	3.2	2.1	7.2	6.3	2.2	3.2	3.1	2.6	2.5	2.8	4.4	7.9	2.3	2.2	2.4	1.8	1.8	2.0	3.1	3.2	1.1	2.5	3.9	2.4	4.9	3.1	3.1	4.5	4.4	2.9	3.0	2.7	2.8	1.9	5.8	3.8	1.9	6.8	8.5	5.6	8.0	7.0	7.2	8.2	4.7	8.4	4.2	0.0	12.6	5.2	10.9	10.4	14.8	7.3	10.2	8.1	11.4	15.7	5.9	28.7	16.6	21.4	5.4	8.0	19.2	23.3	46.6	23.6	21.1	9.2	1.1	30.6	17.2	7.9	4.1	14.7	6.3	6.5	13.3	10.8	30.4	11.8	11.1	28.5	21.0	25.9	9.6	34.3	12.9	32.3	12.5	33.6	22.6	7.5	21.1	4.4	24.9	9.1
ALG2	"CDG1I, CDGIi, FLJ14511, hALPG2, NET38"	ENSG00000119523	"ALG2, alpha-1,3/1,6-mannosyltransferase"	Q9H553	9	99216426-99221956	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041512, HPA041601"	Approved		Enhanced	"Actin filaments,Cytosol"		No	No			"Actin filaments, Cytosol"		"HPA041512: AB_10794380, HPA041601: AB_10794302"	"unprognostic (8.86e-3)"	"unprognostic (4.39e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (8.44e-5)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.06e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.28e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.81e-1)"	12.5	28.0	9.2	9.4	9.7	10.5	16.4	13.1	12.5	18.8	12.9	11.6	31.1	11.0	15.2	39.2	12.3	15.8	13.9	12.1	8.3	9.5	24.8	45.5	16.0	12.8	10.8	6.5	18.4	43.4	14.7	22.4	22.5	12.0	16.7	14.9	14.7	24.1	32.6	13.3	8.7	15.5	12.6	11.3	15.9	15.0	12.6	9.7	14.8	26.0	9.9	15.8	12.9	11.8	16.8	41.0	18.2	18.5	17.5	26.4	17.8	8.1	11.0	8.1	11.6	30.1	19.6	16.7	16.7	26.6	17.1	14.9	13.1	11.8	8.8	7.8	19.2	23.2	32.3	13.7	17.9	17.2	13.3	6.3	5.2	8.7	19.4	36.2	9.1	9.9	21.4	23.4	14.5	26.4	16.5	19.1	5.7	9.1	19.9	15.8	17.1	4.6	10.9	10.5	26.9	15.5	5.3	16.5	13.7	22.9	10.4	8.7	7.1	12.3	22.7	21.5	12.9	9.2	7.8	13.5	11.7	11.6	14.9	10.4	18.7	10.1	3.8	22.0	7.3	5.7	18.2	18.5	11.2	18.6	14.6	26.4	16.8	17.7	18.4	23.0	13.3	15.4	15.0	5.0	17.5	12.9	41.0	18.8	17.8	9.2	9.7	13.1	12.5	8.3	9.5	10.8	6.5	12.0	9.7	11.9	22.2	18.6	17.3	20.7	11.4	6.0	20.4	14.7	14.8	22.7	2.0	44.0	18.3	32.0	22.1	17.7	16.9	0.0	30.7	28.2	25.8	31.0	7.0	52.1	25.7	9.5	12.0	24.5	25.6	16.5	24.7	22.6	20.3	93.8	19.7	13.4	30.1	14.0	23.7	31.7	7.0	6.5	18.9	20.2	23.7	20.7	74.6	15.9	16.8	28.9
ALG3	"CDGS4, D16Ertd36e, Not56, NOT56L"	ENSG00000214160	"ALG3, alpha-1,3- mannosyltransferase"	Q92685	3	184242301-184249548	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.4"	"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 169.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045103	Enhanced					NA	NA					"HPA045103: AB_10960547"	"unprognostic (3.63e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.63e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (1.58e-5)"	"prognostic unfavorable (8.67e-5)"	"unprognostic (6.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.02e-2)"	14.2	24.1	7.7	12.2	10.3	11.6	15.4	7.2	12.9	11.5	15.5	13.7	15.2	14.3	12.8	11.2	20.5	11.5	15.4	13.0	7.3	6.5	19.7	74.4	12.9	16.8	11.5	7.3	12.7	37.7	18.4	11.7	26.6	10.2	14.0	16.0	12.4	20.9	13.7	18.9	18.4	16.3	14.0	7.9	14.9	15.0	20.8	10.1	13.9	15.9	14.9	18.8	17.4	15.8	14.2	30.1	6.0	25.4	18.7	18.0	15.5	20.1	17.6	4.8	16.1	19.4	11.1	16.4	10.9	12.4	14.9	12.8	26.9	13.6	17.8	29.7	13.4	30.2	24.3	17.3	23.6	9.3	12.8	20.1	15.9	13.4	21.6	17.8	25.8	14.4	13.1	19.8	17.6	24.9	7.8	8.1	12.2	15.7	36.0	9.6	24.8	12.5	20.9	15.1	40.2	23.0	13.0	7.5	70.6	16.8	6.7	12.1	10.2	10.1	40.0	17.3	6.1	37.9	14.7	6.5	15.8	10.0	13.8	23.1	19.7	34.6	18.8	14.1	33.9	14.1	0.2	25.4	6.0	16.0	25.0	18.0	14.2	17.3	16.2	30.1	12.3	15.6	15.1	0.9	18.7	19.7	27.4	18.0	15.5	7.7	10.3	7.2	12.9	7.3	6.5	11.5	7.3	10.2	10.1	6.0	14.9	23.1	21.9	22.1	9.4	8.4	22.9	10.7	19.4	19.2	9.8	63.5	6.6	48.3	89.2	15.7	30.3	46.7	54.5	79.0	18.5	26.2	12.7	43.7	62.9	7.9	13.9	14.7	21.8	169.9	11.5	18.6	20.3	15.4	27.2	14.3	42.1	21.0	14.2	23.8	9.9	19.4	19.1	28.7	33.6	23.6	55.0	19.3	41.5	24.2
ALG5	bA421P11.2	ENSG00000120697	"ALG5, dolichyl-phosphate beta-glucosyltransferase"	Q9Y673	13	36949775-37000261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007989	Approved		Approved	Cytosol		No	No			Cytosol		"HPA007989: AB_1078132"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (7.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.86e-1)"	14.7	18.2	11.8	14.0	14.2	11.3	19.9	10.9	13.7	16.7	16.5	10.3	34.2	13.0	13.5	34.8	11.7	12.4	12.9	13.1	10.0	10.5	18.1	36.7	19.1	28.0	16.1	12.8	11.8	60.4	11.8	11.6	17.0	12.1	12.9	20.8	7.3	30.2	37.0	9.0	11.0	12.6	10.9	15.1	12.9	17.6	7.2	14.2	15.4	25.5	12.1	12.4	12.4	11.1	19.1	45.5	17.7	24.8	22.1	25.2	26.9	9.6	13.0	12.0	12.3	33.1	22.2	8.8	26.8	28.5	22.7	18.6	25.4	33.7	13.9	11.1	16.2	19.3	23.9	14.8	20.4	21.2	14.8	29.0	31.9	10.8	15.9	32.4	27.0	16.7	23.3	30.1	18.1	24.3	14.9	17.3	15.6	14.6	17.3	20.5	17.3	18.2	21.6	12.3	60.8	10.6	22.2	14.8	34.0	24.1	18.3	9.6	18.7	11.3	21.0	15.5	9.5	12.7	26.9	13.2	12.7	7.2	14.0	17.0	14.8	11.4	18.2	19.6	17.2	21.0	17.7	24.1	10.0	24.4	24.8	24.6	19.1	23.0	24.4	23.6	17.0	21.2	23.2	2.7	22.1	20.2	45.5	25.2	26.9	11.8	14.2	10.9	13.7	10.0	10.5	16.1	12.8	12.1	14.2	47.6	44.6	33.5	34.8	30.8	16.4	9.7	81.5	22.7	31.8	50.6	9.8	71.9	19.9	78.2	27.2	40.9	34.9	0.0	121.6	63.8	57.3	47.1	28.8	63.8	63.1	11.1	34.7	32.5	37.8	17.9	37.2	44.2	75.9	39.7	51.8	33.6	80.6	45.6	36.0	43.5	23.5	45.3	44.3	47.0	21.3	26.5	68.0	41.5	66.2	37.2
ALG6		ENSG00000088035	"ALG6, alpha-1,3-glucosyltransferase"	Q9Y672	1	63367590-63438562	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062536, HPA076130"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062536: AB_2684792, HPA076130: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	9.7	13.7	9.3	13.5	13.5	8.8	11.6	12.2	12.6	9.9	11.8	10.1	9.0	12.1	11.0	14.3	16.7	9.6	9.1	9.9	11.2	7.1	10.3	14.6	10.0	13.4	8.2	11.1	10.8	11.5	10.6	10.0	14.1	11.6	8.9	14.0	10.2	12.9	11.9	8.0	13.7	13.5	7.5	10.5	14.5	10.0	6.9	8.7	25.9	9.7	8.5	21.7	10.0	11.6	7.5	7.9	24.2	7.4	7.4	10.6	5.6	5.3	4.8	8.5	7.7	10.2	8.8	11.2	6.3	2.2	3.3	3.8	5.6	5.4	13.9	15.2	5.2	14.6	10.3	12.4	10.1	6.0	15.6	9.8	10.7	5.5	4.6	5.0	12.7	9.3	7.3	6.1	8.1	3.0	6.1	12.5	14.2	11.3	11.2	7.7	7.0	12.2	10.7	26.0	14.6	7.2	12.5	12.0	16.4	9.5	7.4	7.9	4.3	16.8	17.5	16.5	16.3	9.7	7.2	6.8	5.5	5.5	11.6	8.1	9.5	13.3	11.5	5.3	12.7	18.4	24.2	7.4	13.6	8.8	6.6	10.6	7.5	7.2	8.5	7.9	5.6	8.7	9.1	4.3	7.4	6.4	6.5	9.4	5.6	9.3	13.5	12.2	12.6	11.2	7.1	8.2	11.1	11.6	8.7	8.9	3.7	7.5	8.0	9.7	5.6	2.8	10.2	4.0	7.9	3.5	3.9	39.5	1.7	10.5	1.9	5.8	5.8	0.0	7.8	23.6	8.2	5.4	9.2	9.2	13.7	6.4	4.1	8.0	5.9	1.7	6.4	7.5	15.1	0.0	7.8	4.9	6.5	0.0	4.6	5.9	5.1	6.5	5.1	12.1	15.9	9.7	22.4	13.8	9.3	6.4
ALG8	MGC2840	ENSG00000159063	"ALG8, alpha-1,3-glucosyltransferase"	Q9BVK2	11	78100936-78139660	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051898	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051898: AB_2681656"	"unprognostic (1.37e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.38e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.37e-2)"	20.2	24.5	18.0	11.2	22.3	9.7	23.7	13.8	17.9	16.5	15.0	20.7	23.9	10.3	14.5	30.9	13.3	18.4	12.3	13.0	15.9	16.0	24.9	40.8	12.8	15.7	16.0	11.6	22.9	23.4	24.2	23.6	21.7	17.1	15.5	19.0	17.6	23.2	19.5	8.2	13.3	13.3	14.8	17.6	13.8	13.1	38.9	16.5	18.2	29.7	13.1	17.4	13.2	11.2	21.9	19.4	3.0	20.3	18.2	19.0	14.9	8.9	24.6	23.6	20.2	20.5	14.4	12.7	13.1	19.7	22.5	21.8	46.6	32.7	20.9	24.3	15.7	29.5	25.7	27.5	18.9	36.4	15.0	16.5	25.2	21.7	20.9	13.3	24.0	16.8	11.5	12.2	26.3	13.1	12.9	16.3	19.0	31.2	21.6	30.1	13.0	20.0	27.1	26.3	60.1	12.9	21.4	10.9	49.8	22.6	13.8	6.9	17.4	18.9	30.7	9.5	22.5	34.3	19.0	10.0	15.3	17.8	34.4	11.3	15.5	30.1	30.9	8.5	23.6	26.4	0.3	17.5	3.0	15.7	19.5	17.5	21.9	16.0	16.1	19.4	16.6	19.0	17.2	1.1	18.2	20.3	18.7	13.0	14.9	18.0	22.3	13.8	17.9	15.9	16.0	16.0	11.6	17.1	16.5	11.9	12.3	25.2	20.6	9.3	13.9	6.3	25.5	10.7	13.6	19.2	17.7	44.1	5.0	18.7	10.7	14.3	6.0	0.0	22.1	52.0	15.3	15.6	11.5	36.4	27.9	15.9	7.5	11.1	14.0	9.8	16.7	17.3	25.3	4.6	15.5	8.2	16.4	5.8	14.9	14.6	12.9	0.0	15.2	115.0	39.1	7.9	27.3	14.9	14.0	15.7
ALG9	DIBD1	ENSG00000086848	"ALG9, alpha-1,2-mannosyltransferase"	Q9H6U8	11	111782195-111871581	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038575	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038575: AB_10672718"	"unprognostic (1.48e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.34e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.07e-3)"	"unprognostic (5.11e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.10e-2)"	19.9	13.5	11.8	11.4	17.9	9.0	16.8	19.3	19.3	16.9	13.7	15.6	15.7	16.2	19.1	15.7	13.8	12.5	14.0	14.3	11.6	13.7	13.7	17.7	12.3	13.5	12.2	11.2	19.2	29.9	21.0	16.5	20.3	14.6	14.7	14.9	17.5	34.3	20.1	11.7	17.3	13.2	15.8	13.2	13.0	14.1	25.0	9.8	15.3	17.4	10.9	15.2	13.8	14.2	7.8	9.5	7.0	7.9	7.1	12.2	6.5	9.9	10.1	19.8	19.4	12.3	11.8	15.0	13.0	10.6	10.8	11.7	17.2	17.0	16.1	18.5	14.6	13.6	18.7	10.3	15.7	15.2	12.4	8.1	12.2	5.9	12.6	14.3	13.7	8.5	10.2	10.6	11.2	11.1	15.5	10.3	12.5	12.2	25.2	17.6	7.3	13.7	12.2	6.5	13.9	11.2	12.6	17.6	31.3	11.8	8.9	9.7	16.7	11.4	17.5	7.0	14.4	18.9	5.6	10.2	22.7	16.0	11.0	14.0	8.2	6.1	15.1	9.4	17.1	15.3	6.7	5.8	7.0	8.5	7.9	9.4	7.8	8.0	8.8	9.5	6.6	12.2	7.3	2.3	7.1	6.9	9.4	7.7	6.5	11.8	17.9	19.3	19.3	11.6	13.7	12.2	11.2	14.6	9.8	0.0	4.1	2.9	1.2	1.8	9.4	5.0	2.5	1.4	4.5	7.0	7.9	3.0	3.3	6.3	4.3	2.1	3.2	0.0	6.1	11.4	2.8	1.2	0.0	5.8	2.7	14.3	4.1	2.5	1.2	3.5	4.4	2.3	0.0	3.6	3.4	5.4	5.9	3.5	3.5	2.2	10.3	6.5	4.1	3.7	5.5	1.4	7.6	2.5	3.9	0.6
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 56.9;SiHa: 107.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		98000000	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	32.0	19.5	4.5	22.5	4.5	22.1	35.1	5.9	3.5	25.4	20.4	6.4	29.1	6.5	19.5	34.1	24.7	26.3	24.2	33.1	3.2	2.5	31.7	91.2	34.9	44.9	5.8	2.2	56.8	20.1	30.2	11.9	79.0	5.9	22.6	11.1	32.1	39.1	42.7	15.0	17.6	18.9	17.7	6.4	38.5	19.9	37.6	3.6	23.1	39.3	16.9	41.0	26.4	21.6	24.8	56.4	24.9	9.1	18.2	16.5	5.4	16.2	12.0	2.2	3.1	11.4	20.2	40.7	17.0	21.3	10.3	10.2	7.3	19.0	6.2	10.8	24.7	13.3	8.8	2.3	21.0	10.3	56.9	2.3	3.5	50.2	5.6	22.5	2.9	6.0	22.5	37.7	11.7	14.3	22.2	10.9	1.9	4.0	7.8	9.7	14.2	2.6	5.8	1.3	9.0	3.7	3.4	2.1	4.1	30.7	14.2	1.7	2.1	107.2	20.9	4.2	7.3	26.4	5.3	10.0	7.3	8.7	23.5	6.6	1.3	2.8	3.9	22.8	4.0	2.7	6.2	9.1	5.0	13.0	7.8	16.5	24.8	8.7	11.4	6.1	20.7	5.3	6.7	24.9	18.2	6.0	56.4	5.7	5.4	4.5	4.5	5.9	3.5	3.2	2.5	5.8	2.2	5.9	3.6	80.4	65.7	101.3	48.3	125.9	1.4	29.7	86.6	26.8	59.1	158.7	19.6	74.7	13.3	63.1	9.2	49.6	45.8	23.3	110.1	134.4	71.0	89.2	36.8	170.8	48.5	0.0	8.1	90.9	71.6	5.1	46.9	58.9	91.1	22.6	42.2	7.2	120.8	32.3	41.8	46.1	39.5	51.8	65.3	4.8	13.4	94.7	145.4	44.5	21.7	74.5
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		12000	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	18.6	8.6	34.5	10.1	22.4	4.6	15.6	8.1	35.7	18.4	16.1	16.1	10.7	9.4	13.3	8.5	20.2	11.4	11.9	23.3	25.3	18.9	8.4	24.2	7.7	4.4	18.9	15.6	15.3	39.5	9.9	10.6	9.9	12.7	13.5	10.4	8.7	21.4	21.5	41.0	19.5	9.4	21.3	16.1	5.2	11.2	11.4	11.3	1.9	9.0	12.1	10.1	16.5	11.7	1.7	0.4	0.1	0.6	0.2	2.6	0.7	20.1	14.7	15.3	26.1	20.9	18.7	15.4	22.8	18.8	18.2	16.7	9.7	17.7	13.2	11.7	36.4	16.7	14.0	13.7	23.3	8.5	13.3	26.0	8.8	10.2	22.1	16.9	8.4	0.3	16.3	27.3	13.0	26.7	19.2	21.0	5.3	16.6	8.6	14.2	14.5	4.4	8.4	21.4	14.4	18.4	15.7	20.6	20.7	12.9	9.4	27.9	23.2	10.0	31.6	15.3	8.0	13.7	10.0	16.5	31.7	40.6	21.9	25.4	3.1	6.0	5.6	14.2	6.4	21.1	0.0	0.2	0.0	2.6	0.6	2.4	1.7	1.2	2.2	0.4	0.5	0.0	2.0	0.1	0.2	0.1	0.2	1.1	0.7	34.5	22.4	8.1	35.7	25.3	18.9	18.9	15.6	12.7	11.3	0.0	12.0	0.8	8.4	6.9	13.5	12.2	7.6	2.7	4.5	14.0	3.9	1.6	1.7	12.6	14.0	7.4	5.8	0.0	17.4	6.6	10.6	10.5	0.0	17.8	2.1	17.5	15.6	4.3	0.6	5.4	15.3	1.8	3.3	2.8	19.7	7.5	21.8	7.0	11.7	8.6	12.0	6.5	6.1	3.5	13.0	11.0	0.5	1.3	13.3	14.9
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 95.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 74.9"	"Low region specificity"	"Detected in all"							HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		74000	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	20.7	18.7	16.5	17.2	22.1	17.3	33.4	20.1	23.2	15.0	19.0	12.4	22.2	18.4	13.6	21.0	20.4	17.2	17.5	17.2	13.4	14.7	22.5	21.7	20.8	21.6	16.4	13.4	25.4	37.5	15.8	29.1	41.0	16.6	18.5	19.3	14.8	33.0	27.8	19.5	20.2	15.1	11.7	14.1	26.6	21.5	28.4	16.4	14.8	28.2	10.7	21.4	20.6	22.9	16.7	22.6	7.1	12.6	15.1	25.5	11.9	9.9	6.6	9.8	12.9	14.6	7.5	15.7	5.7	10.2	11.8	10.9	13.0	20.4	9.2	16.3	6.4	11.3	10.2	10.3	6.3	7.0	9.6	12.6	5.3	4.4	10.4	10.5	10.3	14.8	10.4	9.4	10.9	11.9	14.2	13.4	12.1	17.0	20.8	9.6	10.3	6.7	9.9	12.3	20.1	14.1	8.2	5.5	22.7	10.1	6.2	14.0	16.6	5.7	15.1	11.9	13.9	15.1	18.9	5.6	5.9	10.7	6.7	16.6	74.9	40.4	12.3	8.8	8.9	9.4	5.1	8.9	7.1	17.6	10.1	15.7	16.7	16.7	16.8	10.8	13.5	16.4	15.4	5.9	15.1	12.6	22.6	25.5	11.9	16.5	22.1	20.1	23.2	13.4	14.7	16.4	13.4	16.6	16.4	17.9	18.3	36.5	26.3	34.2	12.6	9.5	7.6	10.7	6.8	24.4	2.0	38.4	5.0	25.4	7.0	20.2	14.7	0.0	19.9	75.2	19.5	33.5	9.2	11.6	25.2	25.4	27.6	26.4	16.8	4.0	8.9	13.8	21.9	6.4	22.4	7.4	28.1	14.4	6.7	17.3	6.3	25.8	34.6	9.8	42.9	36.6	95.5	34.6	21.7	45.5
B4GALT5	beta4GalT-V	ENSG00000158470	"Beta-1,4-galactosyltransferase 5"	O43286	20	49632945-49713878	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 107.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (7.98e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.69e-2)"	20.0	37.2	16.2	13.8	15.8	53.3	15.7	22.6	19.0	15.5	16.4	8.5	10.6	16.5	17.2	7.5	27.4	14.6	21.1	32.7	12.4	12.6	16.8	17.3	20.1	7.7	10.4	9.9	19.5	11.7	7.0	14.1	17.8	17.3	12.4	16.1	15.3	15.7	15.7	46.9	6.4	15.5	24.7	13.5	22.6	16.9	16.6	9.3	3.9	9.5	8.0	13.7	19.2	16.0	0.4	1.1	10.2	1.6	1.7	2.4	0.6	15.8	18.3	24.4	10.3	25.5	17.4	21.4	7.8	14.7	36.0	17.3	23.5	19.8	4.8	33.7	13.0	34.1	25.4	15.3	11.7	21.2	14.9	4.2	12.9	10.0	14.0	8.0	16.7	25.3	26.0	11.0	15.6	7.5	33.3	21.8	8.7	20.8	3.0	10.4	7.9	1.0	15.4	12.7	15.7	11.9	8.7	21.1	7.0	17.3	11.3	29.2	14.8	28.0	35.9	15.7	18.8	8.1	23.1	16.7	21.7	17.5	11.5	16.4	3.7	3.2	11.8	11.3	16.1	13.7	1.3	1.6	3.7	2.2	1.6	2.4	0.3	1.0	2.1	1.1	0.4	0.2	1.5	10.2	1.7	1.6	0.9	1.3	0.6	16.2	15.8	22.6	19.0	12.4	12.6	10.4	9.9	17.3	9.3	14.9	45.0	3.2	24.2	16.8	6.2	15.3	30.6	24.1	35.2	34.9	9.8	19.4	1.7	27.9	4.5	43.9	21.4	23.3	17.1	21.5	24.3	41.5	84.0	20.2	21.9	11.1	33.0	47.3	27.6	5.3	18.4	28.0	20.3	9.0	23.7	5.2	29.8	28.6	30.8	31.6	4.8	25.8	26.8	7.5	17.7	15.3	4.7	15.2	16.4	107.6
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898820	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 125.7"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 113.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		18000000	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	29.0	125.7	12.0	22.8	19.5	22.1	35.3	11.4	30.0	14.1	50.6	17.4	16.2	29.4	18.2	19.3	20.7	12.7	28.0	32.6	11.5	11.6	88.2	43.8	28.4	38.9	12.3	16.1	23.9	19.2	28.3	16.5	47.7	15.7	18.2	50.5	30.1	20.5	15.1	19.3	28.2	40.6	19.6	11.9	38.8	19.7	14.3	11.2	8.0	18.1	24.9	22.4	23.3	18.7	7.0	16.6	81.1	46.1	12.0	31.2	50.0	14.1	14.5	2.7	12.4	113.6	58.9	6.3	20.3	54.2	22.3	29.1	27.3	38.1	3.0	23.6	38.1	84.2	22.6	7.3	13.7	14.0	5.9	6.8	8.0	10.2	47.5	25.3	12.7	33.2	46.7	16.5	14.4	3.2	55.8	24.2	3.9	7.9	46.7	24.1	29.1	3.2	11.8	2.8	21.6	34.6	5.1	14.1	16.8	17.8	12.5	5.5	5.2	33.9	59.3	56.7	7.3	14.5	18.3	22.3	44.8	10.5	25.3	15.9	23.1	29.1	2.1	80.6	16.9	18.4	60.6	46.1	81.1	7.5	26.6	31.2	7.0	12.9	13.2	16.6	3.6	4.7	6.9	24.7	12.0	17.7	6.6	23.9	50.0	12.0	19.5	11.4	30.0	11.5	11.6	12.3	16.1	15.7	11.2	32.8	24.6	40.4	31.0	21.5	54.2	10.9	58.6	22.7	26.1	68.0	56.9	86.8	33.2	172.8	2.3	41.6	257.8	0.0	146.8	91.1	44.1	21.0	9.2	53.3	279.4	44.5	51.9	105.0	166.6	3.6	30.5	81.3	106.3	136.1	70.2	92.8	127.7	92.2	25.8	168.1	30.9	25.8	46.4	6.2	32.4	19.9	120.5	54.2	85.6	31.9
DAD1	OST2	ENSG00000129562	"Defender against cell death 1"	P61803	14	22564905-22589269	"Cancer-related genes, Predicted membrane proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028882	Uncertain		Approved	Cytosol		NA	NA		14000	Cytosol		"HPA028882: AB_10602214"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (9.43e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.37e-3)"	48.1	64.7	47.9	36.4	49.4	26.4	61.2	19.3	39.5	59.0	46.7	55.9	93.6	39.7	49.8	118.7	61.2	56.5	54.9	55.2	45.9	43.1	85.1	123.6	48.4	54.6	51.5	25.1	55.4	114.1	35.6	57.0	54.6	51.9	48.3	51.5	43.5	81.9	100.1	39.7	35.6	73.4	49.6	65.3	57.4	48.0	56.7	33.6	84.6	107.0	50.7	52.2	49.3	43.4	80.2	121.1	75.3	65.9	61.5	95.6	122.5	47.9	45.1	37.1	50.3	101.4	72.9	32.1	51.4	62.3	45.6	64.6	28.3	69.1	30.3	33.0	59.0	51.9	44.0	38.4	49.3	73.2	41.1	35.1	29.6	26.4	112.8	70.7	41.3	43.0	54.1	66.3	47.7	61.5	52.1	66.5	29.4	22.3	71.7	67.1	58.8	19.6	50.5	22.8	106.4	73.8	27.5	31.4	39.5	67.1	39.7	28.5	35.7	39.0	55.9	56.6	46.6	33.7	42.2	50.3	39.8	31.9	48.3	32.3	53.7	62.2	39.1	36.0	29.0	57.4	66.0	65.9	68.1	86.7	56.2	85.1	80.2	90.9	81.7	62.0	71.2	95.6	83.8	75.3	61.5	47.8	121.1	83.5	122.5	47.9	49.4	19.3	39.5	45.9	43.1	51.5	25.1	51.9	33.6	148.9	165.4	142.8	161.3	176.2	21.8	136.5	170.7	219.5	109.2	242.5	25.5	222.0	182.4	458.8	135.7	237.6	168.9	23.3	362.6	309.7	253.7	161.4	292.5	226.5	313.4	20.6	130.4	183.0	140.5	70.6	198.5	173.2	313.8	230.0	162.7	174.4	363.0	131.9	187.0	354.4	32.8	148.8	195.7	167.4	132.2	188.6	241.7	163.9	144.2	147.6
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		3300000	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977"	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	25.7	42.7	17.0	28.7	21.6	37.1	42.5	13.9	26.7	32.8	35.3	16.4	52.0	27.3	37.1	54.7	33.2	32.7	40.0	53.2	13.9	15.7	36.0	59.8	37.2	84.7	16.5	18.3	42.4	146.9	25.4	37.2	71.6	16.1	24.9	39.1	29.5	51.3	58.3	25.5	25.1	35.6	32.2	12.8	49.8	36.5	35.1	15.0	32.5	51.5	28.7	34.5	26.7	30.0	45.6	80.1	50.1	57.1	49.7	58.9	80.7	46.3	29.8	26.0	77.0	51.8	54.2	54.3	39.1	78.7	63.7	65.8	39.6	97.2	38.6	65.3	63.4	35.0	40.3	35.8	47.9	47.2	30.5	36.8	33.3	19.4	52.0	77.2	51.8	86.3	55.5	53.5	53.3	64.5	76.8	72.7	25.9	16.1	64.3	38.2	35.5	24.5	42.8	26.8	74.4	31.6	21.6	34.9	68.4	52.0	20.5	18.9	33.0	42.2	43.0	58.1	39.2	34.4	80.3	37.3	36.8	38.7	63.4	36.0	76.3	82.0	25.9	60.6	69.2	49.3	44.7	55.7	50.1	55.7	57.1	58.9	45.6	48.2	51.3	80.1	39.6	44.1	46.6	14.2	49.7	48.5	65.4	49.2	80.7	17.0	21.6	13.9	26.7	13.9	15.7	16.5	18.3	16.1	15.0	32.8	59.5	70.0	69.0	44.6	15.7	18.9	58.6	75.0	70.5	33.2	27.5	298.3	33.2	141.7	21.4	50.9	44.9	23.3	130.8	225.3	93.6	64.6	76.3	67.1	126.3	15.9	69.0	62.0	66.8	12.2	69.0	83.0	81.0	115.4	106.2	51.5	92.2	91.2	57.3	44.9	19.3	45.3	41.9	107.7	187.2	46.9	292.5	81.2	128.2	58.0
DHDDS	"DS, FLJ13102, HDS, RP59"	ENSG00000117682	"Dehydrodolichyl diphosphate synthase subunit"	Q86SQ9	1	26432282-26471294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Transferase	"Disease mutation, Epilepsy, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 241.5;Rod photoreceptor cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026721, HPA026727"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA026721: AB_1847643, HPA026727: AB_1847644"	"unprognostic (1.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (9.42e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.95e-1)"	31.8	14.4	11.2	10.8	15.9	6.4	15.0	45.9	18.8	10.4	23.1	12.5	8.3	12.2	15.4	21.9	18.9	9.2	10.9	14.8	9.7	10.7	16.2	15.3	9.5	10.3	12.1	15.8	9.8	14.7	23.2	15.5	13.1	20.6	9.6	23.9	22.0	56.9	9.1	10.3	13.1	12.2	11.3	7.6	10.5	14.2	12.9	8.9	9.7	12.1	11.1	16.9	10.6	9.8	11.1	11.2	11.8	19.5	8.1	11.6	8.2	14.9	12.2	8.1	11.1	16.8	14.1	14.0	25.6	16.0	19.8	19.8	18.8	16.5	16.9	15.7	23.9	14.5	10.9	10.9	20.0	19.0	10.3	5.8	16.8	30.3	13.8	15.8	18.3	24.8	19.3	11.9	27.3	15.4	13.3	24.9	11.1	12.0	18.6	18.1	10.2	9.3	7.7	12.8	21.0	16.4	11.2	14.4	14.4	10.7	14.1	11.4	9.1	17.2	19.0	11.3	11.7	14.3	10.3	31.7	13.8	13.4	25.9	14.6	22.7	30.4	18.2	21.7	23.0	13.4	6.5	13.4	7.1	11.6	19.5	8.4	11.1	7.7	7.5	11.2	9.3	6.5	9.0	11.8	8.1	18.0	9.1	7.3	8.2	11.2	15.9	45.9	18.8	9.7	10.7	12.1	15.8	20.6	8.9	8.9	5.6	17.5	7.9	4.0	31.4	13.7	12.7	8.1	10.3	14.0	241.5	15.5	10.0	17.0	55.9	9.0	44.5	0.0	12.6	19.4	8.2	11.0	18.5	11.5	21.3	14.3	20.1	11.1	7.3	16.4	9.8	9.7	10.1	48.7	32.2	15.3	14.8	42.1	7.1	20.3	101.1	0.0	10.3	9.3	13.5	4.4	21.3	10.0	14.0	11.1
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947619	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	11.0	20.2	7.9	7.8	13.8	1.4	9.5	7.0	18.6	9.8	8.6	14.9	7.1	8.8	12.4	16.8	10.9	10.8	10.8	12.0	7.6	9.9	17.5	22.0	10.6	10.6	8.1	6.7	13.2	16.9	19.2	8.0	19.5	16.3	12.3	8.0	14.2	15.5	12.8	7.9	11.4	10.9	11.1	5.9	11.6	12.4	22.4	6.0	12.5	11.0	11.9	12.1	10.4	7.3	9.4	14.2	5.6	16.4	9.8	13.7	9.0	5.1	19.3	6.8	10.1	20.2	10.7	9.3	10.8	17.5	13.3	9.9	15.1	8.2	2.8	5.7	15.6	18.8	36.7	9.3	13.5	6.9	4.7	8.1	3.5	13.3	10.9	20.5	3.8	6.3	14.8	12.5	14.3	7.9	7.8	12.9	4.1	8.6	4.6	14.3	25.4	3.1	3.2	8.8	14.8	12.0	3.2	9.0	11.2	11.9	7.8	6.3	7.0	14.3	11.8	6.3	6.7	20.6	5.1	10.7	12.0	4.3	15.1	8.8	4.4	10.8	2.9	11.3	3.5	9.1	2.3	13.5	5.6	10.2	13.3	9.1	9.4	9.2	11.2	14.2	9.2	12.1	12.3	2.1	9.8	16.4	8.1	13.7	9.0	7.9	13.8	7.0	18.6	7.6	9.9	8.1	6.7	16.3	6.0	6.0	2.6	1.5	3.2	1.5	9.0	3.0	7.6	6.7	3.4	7.0	7.9	21.7	0.0	14.1	10.7	8.3	6.2	0.0	12.3	14.0	5.6	3.1	1.1	8.3	11.4	4.8	1.2	17.2	6.9	2.8	11.2	2.7	3.3	1.8	3.8	11.2	10.4	5.8	5.6	7.2	6.5	0.0	4.1	24.0	14.9	1.1	15.2	1.9	5.5	1.7
DOLPP1	LSFR2	ENSG00000167130	"Dolichyldiphosphatase 1"	Q86YN1	9	129081100-129090438	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019179	Approved		Approved	"Vesicles,Intermediate filaments"		NA	NA			Vesicles	"Intermediate filaments"	"HPA019179: AB_1847827"	"unprognostic (1.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.59e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	6.4	12.8	10.0	6.8	10.6	7.7	6.8	11.7	19.3	8.3	17.1	17.7	8.6	28.6	6.0	7.4	18.8	6.6	9.2	4.1	10.1	10.7	9.4	21.8	6.7	6.6	13.2	10.6	7.7	10.5	10.4	6.9	11.6	12.5	10.0	14.2	6.1	10.3	5.8	5.2	10.3	27.7	6.3	15.2	8.5	11.8	12.2	11.0	9.4	6.3	8.5	9.1	7.8	8.0	8.8	12.5	9.8	8.3	7.9	21.7	7.2	4.1	16.0	15.7	14.4	5.3	4.5	18.2	10.3	6.0	19.6	11.0	20.6	13.9	8.1	9.1	6.4	15.0	30.3	16.1	8.6	8.3	9.4	9.9	10.6	10.8	15.7	9.4	11.0	13.2	4.9	12.1	12.8	10.2	4.5	8.7	15.1	17.5	8.1	5.5	21.0	12.5	11.4	13.5	30.9	13.0	14.8	12.7	14.5	7.1	6.7	18.0	11.8	13.0	11.8	4.3	9.6	21.7	7.3	7.1	16.9	8.1	15.9	13.9	10.1	19.4	12.3	7.5	2.2	11.1	4.4	6.8	9.8	8.9	8.1	21.7	8.8	10.9	10.8	8.5	6.0	11.1	10.5	1.4	7.9	8.3	12.5	10.1	7.2	10.0	10.6	11.7	19.3	10.1	10.7	13.2	10.6	12.5	11.0	6.0	4.6	3.7	2.9	2.1	3.2	1.6	5.1	0.0	2.3	1.8	5.9	16.9	1.7	5.9	0.5	2.4	26.6	0.0	8.4	11.4	3.3	2.7	5.7	17.0	6.5	3.2	3.5	6.2	3.8	0.4	2.0	2.3	5.0	4.6	9.0	9.1	5.4	13.3	3.9	3.8	3.4	0.0	3.1	4.5	8.7	3.4	13.7	3.8	12.2	3.4
DPAGT1	"ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT"	ENSG00000172269	"Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1"	Q9H3H5	11	119096503-119108331	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053878	Approved					NA	NA					"HPA053878: AB_2682288"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.50e-2)"	"unprognostic (8.53e-3)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (2.52e-1)"	"unprognostic (3.95e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.08e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.57e-2)"	13.0	20.0	6.8	9.7	6.7	5.5	10.0	5.2	9.3	13.2	13.1	8.5	13.0	11.0	10.9	12.0	14.5	11.6	11.3	8.3	5.9	5.8	12.5	53.0	10.0	6.9	7.5	3.6	11.6	32.1	18.4	5.8	12.5	7.4	10.6	11.1	8.1	26.3	13.6	8.0	6.9	15.3	10.6	6.4	12.2	11.9	5.4	8.0	7.7	11.8	7.2	12.4	16.1	8.3	10.1	16.4	9.2	14.4	7.6	11.8	8.0	5.2	13.4	4.7	14.4	18.0	10.8	6.4	9.7	10.2	6.5	9.8	13.1	22.4	11.3	15.3	13.8	16.1	17.1	13.1	17.6	7.5	6.2	7.1	20.1	4.3	16.0	14.9	12.7	10.1	13.9	14.7	17.7	24.7	6.9	15.1	5.4	12.4	21.8	14.6	16.8	3.1	7.7	5.3	37.8	15.0	5.2	6.4	15.7	16.8	12.5	6.3	6.4	7.1	23.7	3.9	9.2	32.0	5.2	7.7	16.2	6.1	7.2	5.1	3.1	8.4	3.7	3.0	16.3	12.5	9.2	14.4	1.4	9.8	13.2	11.8	10.1	7.5	9.7	16.4	7.3	6.0	6.0	1.4	7.6	11.5	15.2	6.7	8.0	6.8	6.7	5.2	9.3	5.9	5.8	7.5	3.6	7.4	8.0	6.0	7.2	16.2	12.6	11.7	6.2	4.5	25.5	21.4	7.9	14.0	13.7	29.2	3.3	26.6	0.9	13.6	12.9	0.0	11.6	36.9	7.2	12.6	12.7	21.2	25.7	3.2	9.8	14.7	12.3	1.1	13.0	11.7	8.5	20.8	18.1	6.7	14.5	13.6	7.8	10.0	3.5	0.0	8.6	4.4	11.3	10.9	19.7	8.7	18.3	11.9
DPM1	"CDGIE, MPDS"	ENSG00000000419	"Dolichyl-phosphate mannosyltransferase subunit 1, catalytic"	O60762	20	50934867-50958555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA051818	Approved					NA	NA					"HPA051818: AB_2681624"	"unprognostic (2.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.74e-1)"	32.3	39.7	20.2	23.3	30.0	32.9	29.0	22.5	35.1	31.1	28.1	21.3	28.9	24.0	29.9	32.9	36.0	25.6	24.0	38.7	22.2	21.5	41.7	54.0	24.2	33.0	21.6	17.2	30.8	38.9	21.2	35.1	43.9	31.4	29.8	28.9	22.8	35.9	31.5	44.7	27.1	35.6	24.9	21.1	38.6	30.4	25.6	21.7	36.1	34.5	49.1	36.4	35.3	28.3	20.7	25.0	22.2	19.6	20.3	25.1	15.7	35.1	14.3	22.1	13.1	19.2	21.9	24.3	13.9	16.0	27.0	21.4	64.3	28.5	21.5	30.4	18.0	37.5	40.5	17.7	33.1	27.5	10.3	14.1	22.3	18.5	43.3	27.4	35.2	13.4	18.7	49.0	18.7	19.5	17.6	20.6	23.0	33.5	27.2	26.8	15.5	31.9	37.3	22.5	33.5	32.6	17.7	32.3	28.4	26.9	21.3	16.6	18.2	36.1	53.2	46.5	17.6	36.3	41.8	17.0	34.7	28.9	20.4	28.7	19.4	24.6	30.8	38.3	23.6	15.7	12.2	16.8	18.6	19.0	19.6	23.0	20.7	21.8	20.3	21.9	19.3	23.7	25.1	22.2	20.3	18.9	25.0	21.0	15.7	20.2	30.0	22.5	35.1	22.2	21.5	21.6	17.2	31.4	21.7	17.9	40.2	52.1	126.5	103.5	11.0	36.2	20.4	77.6	43.3	29.6	2.0	133.8	99.5	63.9	164.3	51.0	28.1	0.0	64.4	83.7	58.2	65.2	73.8	70.4	77.2	4.8	22.5	57.7	38.4	28.0	52.6	51.7	47.2	68.5	43.2	26.1	60.1	46.0	48.4	73.6	10.2	71.1	61.3	110.0	113.4	92.2	205.3	55.3	48.2	127.0
DPM2	"MGC111193, MGC21559"	ENSG00000136908	"Dolichyl-phosphate mannosyltransferase subunit 2, regulatory"	O94777	9	127935099-127938484	"Disease related genes, Predicted membrane proteins"			"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 163.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064623	Approved					NA	NA					"HPA064623: AB_2685303"	"unprognostic (8.30e-3)"	"unprognostic (1.07e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (2.20e-4)"	"unprognostic (3.67e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.62e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.71e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-1)"	9.6	13.6	15.2	6.9	18.0	8.5	12.3	8.4	19.4	14.3	11.3	9.7	14.7	10.4	8.0	18.7	12.2	19.8	12.9	6.8	15.4	12.1	16.9	17.9	11.1	9.5	14.4	11.5	10.3	27.2	15.6	10.9	16.0	11.3	10.3	8.9	14.3	21.0	13.4	5.1	9.7	8.9	10.8	9.4	9.4	31.9	13.6	8.4	7.9	22.1	11.9	13.9	7.4	7.9	25.2	25.0	15.4	20.6	17.7	22.5	14.7	6.6	14.3	4.9	4.5	13.4	8.8	5.3	9.0	7.7	7.3	4.7	7.9	9.5	4.5	5.1	15.6	13.1	8.2	4.8	15.2	3.9	10.2	11.5	5.4	15.4	8.4	17.1	9.9	7.3	9.8	11.0	12.2	16.9	7.0	10.5	12.2	11.2	6.3	10.8	29.2	3.7	11.3	7.5	30.9	10.8	3.4	5.8	28.0	13.3	5.7	3.5	11.2	9.0	9.2	6.3	4.4	12.3	7.8	5.8	4.1	4.4	4.9	7.5	14.5	18.6	2.9	16.8	5.7	6.5	11.6	17.4	15.4	22.5	20.6	19.5	25.2	16.7	21.0	20.0	23.3	13.8	17.2	7.3	17.7	16.6	25.0	14.0	14.7	15.2	18.0	8.4	19.4	15.4	12.1	14.4	11.5	11.3	8.4	26.8	31.5	25.3	30.5	24.0	23.8	11.1	40.8	25.4	30.7	38.4	15.7	72.6	38.1	50.5	5.6	29.0	35.6	163.5	51.4	89.2	38.5	52.1	28.8	27.0	72.2	36.5	31.2	35.0	23.0	9.4	24.5	25.5	30.4	60.5	41.7	24.6	49.5	34.5	19.1	39.2	18.6	6.5	28.8	14.9	20.7	30.2	54.3	30.5	40.4	32.7
DPM3	"MGC125904, MGC125905, MGC34275"	ENSG00000179085	"Dolichyl-phosphate mannosyltransferase subunit 3"	Q9P2X0	1	155139891-155140595	"Disease related genes, Predicted membrane proteins"			"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014667	Approved					NA	NA		160000			"HPA014667: AB_1847848"	"unprognostic (6.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.83e-3)"	"unprognostic (4.71e-1)"	"prognostic favorable (8.97e-5)"	"unprognostic (1.42e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (8.64e-4)"	21.6	32.2	18.8	14.6	21.3	21.8	28.4	13.0	20.7	25.9	36.1	14.6	43.4	31.0	23.4	42.9	19.6	25.1	31.7	26.1	17.4	18.0	23.9	42.5	19.2	17.9	18.1	15.3	19.9	62.6	9.2	32.7	12.4	14.3	22.3	9.9	23.7	42.1	44.8	29.6	13.4	23.4	23.3	15.1	20.0	24.2	21.5	12.2	13.1	47.0	22.2	11.9	17.3	18.1	43.3	49.6	40.4	45.2	36.4	42.1	37.6	22.6	25.3	7.9	18.6	14.6	13.6	8.5	7.5	9.5	10.1	10.6	8.0	26.8	7.3	23.0	6.1	3.4	16.3	3.0	8.7	1.2	10.4	52.3	8.1	37.6	27.1	13.8	7.2	10.8	13.4	16.1	7.3	3.1	4.9	11.7	18.5	9.0	39.4	7.5	54.9	15.9	16.6	19.6	26.6	19.7	13.8	9.0	43.7	12.1	15.7	13.9	28.7	17.0	20.3	27.0	3.0	14.0	35.2	9.3	6.3	15.2	8.9	10.8	33.5	16.9	21.9	16.5	15.7	4.7	20.3	45.2	40.4	38.8	27.8	42.1	43.3	41.4	37.9	43.7	41.8	39.7	37.9	25.0	36.4	27.6	49.6	32.6	37.6	18.8	21.3	13.0	20.7	17.4	18.0	18.1	15.3	14.3	12.2	47.6	64.3	56.3	56.1	24.4	27.7	97.4	104.4	92.3	59.1	167.5	9.8	59.1	56.3	50.1	36.1	63.7	136.5	0.0	141.2	58.3	64.6	65.2	69.3	221.9	77.0	12.7	95.4	77.3	64.8	9.5	85.7	58.5	92.8	28.9	187.9	74.4	61.4	155.6	91.9	122.9	22.5	38.8	60.8	23.6	10.6	29.5	34.1	44.9	139.7	53.3
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074939-79088599	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 51.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Enhanced		Approved	Centrosome,Cytosol		No	No			Cytosol	Centrosome	"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.73e-5)"	10.0	10.1	9.5	20.7	18.4	8.9	11.4	7.0	13.9	10.9	15.1	12.4	8.8	20.3	11.4	6.8	6.5	10.6	8.6	10.3	9.3	5.8	9.2	10.2	10.1	10.7	16.8	8.5	16.3	9.3	11.3	9.8	8.1	13.6	12.3	12.5	10.7	12.1	9.6	35.4	11.9	17.3	7.3	11.9	24.9	11.4	3.9	14.0	8.1	13.6	7.0	9.1	17.5	51.4	0.2	0.7	0.0	1.1	0.0	2.1	0.6	4.5	9.8	3.4	6.3	3.6	1.5	6.6	3.5	1.8	2.9	2.0	5.2	5.0	0.0	4.2	3.5	4.8	6.8	5.4	3.8	1.6	2.7	7.3	4.1	10.0	3.1	2.7	4.7	7.8	4.1	5.3	2.5	2.8	5.6	3.0	8.9	5.9	2.9	1.8	3.9	0.4	4.5	1.5	9.5	8.8	8.6	11.7	3.0	1.5	12.9	2.9	5.7	5.6	25.9	2.6	5.3	9.1	4.4	3.9	5.6	4.2	4.8	3.4	6.9	1.2	2.0	2.3	8.7	4.0	0.0	0.7	0.0	0.0	1.1	0.9	0.0	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.6	2.1	0.6	9.5	18.4	7.0	13.9	9.3	5.8	16.8	8.5	13.6	14.0	0.0	13.6	6.4	3.8	3.9	10.7	4.8	7.6	0.0	6.8	10.4	33.4	4.2	0.0	3.5	1.5	6.5	16.4	0.0	3.6	3.8	4.8	7.4	4.7	10.6	7.5	7.9	25.1	9.8	10.8	1.0	3.1	8.2	0.0	5.4	15.9	5.6	2.5	11.5	1.8	1.7	24.7	12.9	6.0	2.2	1.4	5.1	5.6	5.7	18.8	4.1
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	21.0	57.8	19.3	17.6	26.5	16.5	19.8	12.8	32.2	19.0	25.0	22.6	14.5	45.9	18.0	21.7	41.4	16.7	18.8	19.6	18.6	23.4	23.7	100.8	25.7	19.2	19.5	24.3	15.2	27.5	15.6	12.3	20.2	47.3	16.5	29.7	20.5	29.2	12.9	15.7	29.3	32.3	18.9	23.0	17.7	23.4	15.1	16.5	25.1	19.5	41.7	27.3	13.7	20.8	41.1	39.7	49.4	37.1	45.3	45.5	48.3	36.0	19.6	72.1	26.0	16.9	62.0	25.7	17.2	34.1	27.5	44.8	31.7	85.9	27.5	41.9	15.0	65.7	40.3	42.9	149.6	25.8	15.0	30.7	15.9	35.0	38.3	27.8	25.8	18.3	44.1	23.7	43.7	22.0	12.5	47.9	40.8	28.5	74.2	28.6	38.7	33.0	25.1	43.3	26.8	28.7	28.5	31.3	76.3	72.5	24.1	28.1	24.0	17.7	32.3	29.7	42.9	23.3	70.2	34.8	15.4	18.9	9.5	31.4	31.5	24.2	49.1	15.0	27.6	24.2	30.5	36.0	49.4	39.4	37.1	35.0	41.1	34.8	39.8	39.7	34.2	31.5	39.3	16.5	45.3	27.2	31.4	45.5	48.3	19.3	26.5	12.8	32.2	18.6	23.4	19.5	24.3	47.3	16.5	68.5	144.0	64.8	78.5	32.6	65.5	1.4	107.0	85.6	83.0	50.6	58.9	177.4	116.0	154.2	171.3	113.0	197.2	93.5	286.2	162.6	57.3	89.5	62.2	111.9	95.6	52.4	68.5	133.8	57.6	52.3	56.4	56.4	91.1	217.4	74.5	75.0	194.9	143.8	66.1	113.5	78.0	71.1	63.8	41.9	15.5	52.2	120.0	77.8	106.3	110.3
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868294	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 182.1;Paneth cells: 168.7;Syncytiotrophoblasts: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced				"Intracellular and membrane"	NA	NA		65000000			"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	15.8	18.0	4.6	24.1	7.1	0.9	8.9	4.2	8.1	13.1	30.2	6.9	28.4	20.4	9.9	35.7	8.7	12.7	22.6	15.0	4.7	6.4	28.9	39.3	20.7	66.7	4.8	4.7	19.4	15.5	12.2	10.9	31.9	8.0	15.2	33.5	13.8	22.6	18.5	6.9	6.6	42.3	7.4	7.1	32.3	14.8	15.6	2.9	11.6	27.3	8.0	25.1	23.6	7.8	8.3	15.2	16.8	34.8	14.4	9.9	19.0	5.3	3.6	0.7	11.0	1.5	0.1	3.8	5.7	11.9	6.0	11.2	4.9	56.8	8.0	14.4	7.2	6.6	3.2	5.3	12.1	7.9	5.6	8.8	6.6	3.3	10.9	5.1	0.6	22.0	5.5	6.9	2.2	2.9	19.5	2.4	4.6	3.0	0.1	7.1	5.8	1.6	5.9	1.8	16.2	5.8	9.0	0.0	8.7	22.2	13.8	3.8	3.7	16.4	6.4	8.6	6.6	4.7	2.6	0.6	2.0	3.2	13.6	1.9	10.0	10.1	2.9	5.1	19.9	3.2	13.7	34.8	16.8	9.9	34.5	8.5	8.3	7.2	8.4	15.2	4.7	7.0	8.2	4.3	14.4	28.7	8.8	7.0	19.0	4.6	7.1	4.2	8.1	4.7	6.4	4.8	4.7	8.0	2.9	23.8	22.9	10.4	24.6	3.2	3.4	5.7	40.8	24.1	30.7	80.3	0.0	146.1	13.3	48.0	39.6	10.1	182.1	0.0	44.7	19.3	14.8	27.9	8.1	29.4	139.0	0.0	10.4	23.9	89.5	15.5	21.6	35.0	8.5	9.0	39.6	13.3	29.7	168.7	18.4	28.4	4.8	6.5	5.6	78.8	10.6	2.5	167.7	13.8	63.2	33.2
FUCA2	"dJ20N2.5, MGC1314"	ENSG00000001036	"Alpha-L-fucosidase 2"	Q9BTY2	6	143494811-143511690	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031659, HPA031661"	Approved				"Secreted to blood"	NA	NA		53000000			"HPA031659: AB_10600661, HPA031661: AB_10601681"	"unprognostic (1.83e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (2.70e-9)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.76e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.07e-2)"	22.6	32.6	10.3	14.2	16.2	11.6	24.1	6.2	11.4	18.5	21.2	17.6	23.1	22.0	17.9	24.8	11.9	17.2	25.0	25.6	11.6	11.8	34.1	45.7	21.7	30.0	20.4	8.7	21.9	32.6	52.3	14.4	40.7	16.9	12.0	28.4	21.4	18.9	24.5	6.7	9.3	29.5	14.6	18.5	20.3	20.4	11.0	16.1	3.6	17.9	8.7	10.3	16.7	15.0	4.1	22.9	9.3	29.3	9.7	6.7	14.9	23.3	13.7	11.9	21.7	17.8	35.0	22.7	22.1	23.7	27.3	46.5	26.1	23.5	0.0	16.6	29.6	8.6	0.1	6.0	2.9	38.0	20.9	23.0	7.8	25.6	39.3	25.7	0.0	4.0	18.6	17.5	24.4	10.6	23.3	27.7	0.0	27.8	12.3	30.7	27.6	0.0	18.2	15.5	10.7	18.9	0.0	25.1	17.3	32.4	14.6	9.0	5.9	24.3	16.3	19.8	9.6	8.0	19.3	16.2	16.3	13.8	40.6	42.5	4.5	4.9	0.1	18.8	14.4	5.6	9.3	29.3	8.7	4.9	28.8	5.6	4.1	3.6	4.1	22.9	2.5	1.6	3.0	2.0	9.7	20.0	3.5	6.7	14.9	10.3	16.2	6.2	11.4	11.6	11.8	20.4	8.7	16.9	16.1	38.7	28.1	11.5	10.0	10.0	2.5	22.9	30.6	22.7	15.9	24.4	0.0	45.1	10.0	64.9	1.4	23.4	39.4	23.3	109.4	92.6	60.3	14.4	36.9	31.6	98.2	1.6	9.2	25.8	46.4	0.9	61.9	43.0	40.5	41.5	35.4	11.3	60.3	28.1	42.8	36.9	0.8	6.5	23.7	3.7	3.6	6.9	38.8	12.9	49.1	15.7
FUT8		ENSG00000033170	"Fucosyltransferase 8"	Q9BYC5	14	65410592-65744121	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017129, HPA043410"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB017129: , HPA043410: AB_2678467"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.09e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	7.2	7.6	16.2	12.0	21.1	3.3	9.4	24.1	18.1	6.7	9.8	29.1	16.1	15.4	8.7	5.0	6.5	14.0	10.1	5.2	19.8	12.9	6.2	2.9	7.0	11.2	20.5	11.2	7.2	10.5	6.2	5.2	18.8	17.3	5.4	10.4	7.1	33.7	13.7	3.5	4.9	15.1	9.5	39.8	8.5	27.6	13.1	23.6	8.4	7.5	2.4	15.2	14.4	5.6	13.5	2.2	0.5	1.7	12.0	8.2	2.5	34.4	6.8	3.3	30.3	14.6	11.0	20.5	11.1	17.0	7.7	8.6	5.3	12.7	9.2	9.5	10.9	21.2	2.6	7.8	3.0	11.8	34.0	3.4	9.2	2.5	6.9	7.5	2.0	7.6	27.7	2.0	10.6	5.0	33.8	19.5	4.5	3.4	7.8	5.5	17.7	9.8	5.1	4.4	16.0	23.9	6.7	2.9	5.3	13.8	9.7	7.0	5.3	5.9	2.8	2.4	20.7	2.8	3.3	42.5	10.1	10.9	4.5	8.9	15.7	6.0	21.9	20.5	3.6	3.2	0.5	1.7	0.5	3.5	0.6	3.5	13.5	5.6	5.1	2.2	6.8	6.1	6.0	0.2	12.0	1.1	2.2	8.2	2.5	16.2	21.1	24.1	17.3	19.8	12.9	20.5	11.2	17.3	23.6	11.9	33.3	42.9	6.7	10.8	10.6	5.6	10.2	16.0	22.7	12.2	3.9	38.8	0.0	7.7	28.3	11.3	6.8	0.0	28.1	24.2	15.8	5.7	7.0	3.2	11.0	7.9	5.2	15.4	12.1	10.9	11.8	7.0	1.7	1.8	17.5	35.8	36.1	8.5	12.7	7.8	8.0	0.0	10.3	31.6	26.2	8.5	11.8	13.8	9.4	4.6
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 7.1;granulocytes: 19.3;monocytes: 11.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433, HPA074225"	Supported		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2400000	Cytosol		"CAB026404: , HPA042433: AB_2732499, HPA074225: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	11.9	14.9	9.3	11.2	11.1	25.0	14.8	12.9	15.4	11.1	15.5	11.5	8.8	13.3	9.0	19.9	10.2	14.8	12.7	12.5	11.2	13.9	13.7	17.8	14.7	10.6	11.8	5.2	11.9	7.3	9.9	13.2	15.6	11.6	10.5	8.3	7.1	10.6	9.0	7.1	10.0	17.2	9.4	9.4	10.4	9.5	27.4	8.8	7.9	14.5	6.1	9.0	11.1	13.0	2.1	7.1	19.3	11.2	2.4	3.1	4.7	2.5	19.6	2.8	20.1	22.7	10.9	19.7	8.2	12.8	9.0	7.0	10.2	17.0	3.2	17.4	13.4	13.6	15.1	4.1	6.5	5.5	2.1	6.5	2.0	8.0	5.8	15.3	1.5	13.3	15.2	12.7	10.1	2.8	12.9	7.7	3.5	4.4	1.9	5.3	15.0	4.1	6.5	6.6	6.5	9.1	8.7	2.5	5.4	5.6	6.0	7.4	5.7	19.5	1.8	9.7	7.2	12.7	14.4	14.4	19.8	15.1	20.2	4.5	2.0	1.9	5.5	21.5	13.3	11.7	0.9	11.2	19.3	3.1	8.0	2.6	2.1	1.8	2.7	7.1	0.9	1.7	2.1	14.2	2.4	5.6	3.0	3.0	4.7	9.3	11.1	12.9	15.4	11.2	13.9	11.8	5.2	11.6	8.8	14.9	4.5	1.9	6.4	5.8	3.9	6.7	2.5	26.8	7.9	3.5	5.9	7.9	3.3	5.3	14.3	4.9	12.3	0.0	3.0	11.4	10.2	5.7	1.1	5.7	17.8	23.8	11.5	7.4	13.9	28.0	6.6	8.0	6.8	20.8	6.9	8.5	5.4	12.4	6.3	4.5	9.7	6.5	9.2	49.5	33.7	5.0	13.3	5.7	8.6	5.1
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		37000000	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.54e-4)"	33.6	34.6	16.2	23.3	20.7	17.9	30.1	19.9	31.0	38.9	31.5	29.8	43.4	26.0	44.0	38.6	29.2	34.2	33.8	32.6	17.2	16.5	35.9	91.5	31.4	30.2	21.7	19.5	49.0	51.4	56.6	27.3	61.1	20.0	29.4	32.6	33.7	43.5	40.7	28.2	24.5	39.8	37.4	19.5	37.4	31.2	27.7	20.2	41.8	45.6	25.2	34.0	36.0	29.4	14.6	17.5	16.5	18.8	22.5	20.0	17.6	42.5	37.3	46.7	84.6	72.1	63.1	50.6	48.0	72.1	66.5	57.5	31.1	79.2	29.2	97.1	84.8	52.9	58.2	56.3	53.9	68.9	23.5	24.3	28.8	51.2	12.9	53.3	44.6	36.3	61.2	35.0	66.1	69.4	84.2	61.6	30.0	40.8	52.7	59.7	37.4	23.2	14.5	39.5	35.0	30.3	31.0	56.0	73.3	32.6	34.8	24.7	33.5	68.6	44.5	51.1	52.5	58.3	38.1	46.3	66.6	42.6	52.2	44.6	52.9	61.2	22.3	73.1	24.0	64.7	16.5	15.0	14.4	20.0	18.8	20.0	14.6	13.8	15.9	17.5	13.1	17.9	16.3	7.0	22.5	16.4	11.6	13.0	17.6	16.2	20.7	19.9	31.0	17.2	16.5	21.7	19.5	20.0	20.2	11.9	26.8	19.7	22.3	25.1	29.5	6.5	61.1	10.7	7.9	64.6	56.9	71.8	5.0	43.0	15.3	31.5	35.1	0.0	36.9	114.6	43.7	31.3	10.5	80.2	51.7	33.4	30.6	51.5	41.2	11.0	54.1	24.9	33.7	36.9	50.5	40.2	38.3	25.9	64.0	24.2	33.9	32.3	26.7	18.4	48.6	27.4	67.1	24.2	55.2	26.0
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 164.1;Late spermatids: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029472	Enhanced					NA	NA					"HPA029472: AB_10696206"	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.5	24.8	26.8	16.2	25.7	6.8	33.4	30.1	28.7	24.9	23.1	19.9	21.8	19.8	22.8	30.3	24.1	20.9	19.2	21.8	25.4	25.8	26.4	20.0	18.9	18.3	24.4	22.0	23.5	16.0	19.0	29.3	24.2	25.8	29.0	23.2	15.9	27.8	21.9	26.8	19.0	20.6	24.9	28.3	20.4	20.1	42.5	25.6	22.6	27.9	21.2	20.0	26.9	17.9	28.5	22.2	33.9	35.9	22.1	31.3	26.0	16.6	9.0	22.7	17.0	17.7	25.6	8.9	14.9	20.8	9.8	13.9	7.0	26.6	11.3	21.6	16.3	16.0	13.6	12.0	15.3	13.1	11.5	22.4	9.6	8.6	11.8	20.0	11.8	8.2	16.6	27.6	13.3	18.0	17.4	17.4	19.1	22.9	10.2	12.9	9.8	14.6	14.1	19.4	44.2	4.7	9.0	7.1	12.8	27.4	9.0	18.2	25.2	11.1	25.6	21.3	8.7	31.9	18.8	14.7	11.8	8.9	19.9	13.9	17.8	21.5	13.8	14.9	13.3	21.1	26.6	22.8	33.9	24.8	26.8	24.9	28.5	31.3	26.4	22.2	23.4	29.2	26.5	20.6	22.1	35.9	18.4	30.0	26.0	26.8	25.7	30.1	28.7	25.4	25.8	24.4	22.0	25.8	25.6	29.8	37.5	16.7	58.0	35.4	29.3	20.4	20.4	17.4	15.9	19.2	41.2	26.1	61.3	31.7	164.1	29.1	23.6	0.0	25.0	30.3	35.7	57.0	23.2	12.4	23.9	46.1	16.7	28.3	22.2	214.2	33.1	33.8	64.1	33.3	21.8	38.1	25.9	24.1	32.9	45.5	48.9	25.8	42.4	62.3	46.6	35.5	39.4	32.6	20.4	46.7
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.8	10.0	6.5	7.7	39.9	20.7	139.7	9.3	25.2	12.0	15.4	14.2	13.8	2.8	8.3	19.0	8.9	5.6	6.1	11.9	8.9	16.3	5.1	11.2	6.0	7.3	20.5	7.7	11.4	23.9	11.4	10.8	6.4	23.6	18.4	3.9	10.1	10.9	13.1	6.8	4.6	5.1	4.4	12.2	4.4	4.0	4.3	13.2	12.9	8.5	2.0	6.8	12.0	19.4	11.7	12.0	12.9	20.4	10.7	7.7	5.4	10.5	7.9	8.6	13.7	0.9	16.2	11.2	5.8	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0	17.9	22.3	15.9	10.2	5.4	11.3	7.1	35.7	14.7	17.0	26.2	5.9	80.5	23.2	42.1	22.3	10.5	31.5	0.0	31.3	47.6	24.4	11.4	26.5	36.5	70.6	4.8	16.3	18.4	38.2	3.1	14.1	38.3	13.5	81.2	22.4	20.0	27.0	39.5	19.8	24.2	15.0	12.9	10.8	1.1	7.2	3.0	41.1	20.0	28.4	8.4
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340919-72376476	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	30.1	37.4	23.1	18.0	22.9	35.5	37.8	23.3	28.1	30.6	20.5	19.4	30.1	18.5	25.9	65.7	11.7	21.8	29.2	33.8	23.4	12.8	34.6	29.5	43.9	31.4	24.9	21.1	20.9	22.2	18.1	22.9	37.9	18.8	18.1	26.0	26.9	24.8	22.0	17.7	17.9	24.6	23.4	21.4	31.5	22.6	18.0	22.9	12.1	31.2	11.1	16.4	26.7	17.1	16.1	37.9	22.4	32.7	17.8	18.1	21.3	7.5	12.8	5.5	10.6	45.5	51.9	7.9	10.6	53.8	23.0	36.8	6.7	55.4	6.3	10.2	21.3	12.0	15.1	14.6	6.7	14.6	5.1	5.8	7.9	12.7	11.6	35.2	18.9	22.7	44.1	20.2	10.0	17.9	42.2	21.0	9.4	12.2	39.2	30.6	6.5	4.1	9.5	3.1	24.7	0.1	4.2	12.0	14.2	25.7	11.9	4.8	5.3	26.5	25.1	59.9	11.7	4.6	23.9	10.6	34.5	14.4	31.7	11.2	20.9	28.2	6.5	12.5	25.3	16.7	8.9	32.7	22.4	18.1	13.7	15.8	16.1	12.0	15.8	37.9	15.6	9.5	14.0	3.1	17.8	4.8	14.4	10.7	21.3	23.1	22.9	23.3	28.1	23.4	12.8	24.9	21.1	18.8	22.9	59.6	55.5	41.1	30.3	19.7	40.2	22.6	35.7	17.4	28.4	62.8	100.1	116.3	51.4	65.3	16.3	43.0	46.2	0.0	33.3	55.3	62.5	30.5	29.9	37.8	207.1	25.4	45.3	44.2	76.0	10.5	68.7	108.5	89.4	50.5	39.4	48.4	43.8	84.5	42.1	55.5	56.1	45.3	20.6	20.4	28.2	13.7	131.8	47.5	44.4	25.0
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 174.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 395.6;Hofbauer cells: 319.1;Syncytiotrophoblasts: 412.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 108.4;GAMG: 90.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		43000000			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	48.0	21.9	7.7	13.6	11.6	11.1	26.1	7.4	11.2	25.8	34.2	9.5	18.0	21.6	22.1	77.3	20.6	17.3	28.1	46.3	7.1	9.1	30.4	44.5	40.9	19.3	8.5	6.7	22.7	30.4	21.8	14.3	174.3	9.3	22.6	26.3	21.0	34.6	13.3	21.0	15.3	33.6	21.0	8.7	20.5	20.7	16.2	6.1	10.8	33.7	15.2	15.4	24.0	19.7	8.9	59.8	23.8	65.9	7.6	16.4	42.9	20.3	16.0	5.6	18.5	108.4	33.5	18.2	25.0	81.1	24.4	53.0	18.8	26.6	0.0	19.8	20.5	90.2	16.4	6.0	25.4	32.3	11.4	10.8	2.6	15.5	14.1	31.8	2.2	22.0	29.5	15.0	25.6	17.2	38.5	27.9	6.4	7.5	33.3	26.7	20.6	2.6	5.1	5.2	19.3	7.2	6.2	8.1	26.5	16.8	18.6	3.6	4.5	19.4	13.2	24.1	10.1	13.9	15.1	16.6	16.1	4.0	29.6	23.0	15.4	26.5	0.1	36.7	20.0	29.2	14.5	65.9	18.6	14.2	24.5	16.4	8.9	11.7	13.1	59.8	5.5	11.2	10.9	23.8	7.6	14.6	18.0	13.7	42.9	7.7	11.6	7.4	11.2	7.1	9.1	8.5	6.7	9.3	6.1	38.7	35.5	39.5	70.4	39.0	9.5	18.9	63.7	20.1	18.2	27.9	7.9	395.6	16.6	123.0	1.1	60.6	71.9	0.0	111.0	143.1	100.1	65.8	69.2	62.8	319.1	9.5	21.9	83.4	134.6	1.7	78.9	151.2	69.2	83.8	50.0	34.8	68.2	51.8	67.8	65.5	10.6	45.3	54.5	0.2	1.1	28.4	412.8	37.3	76.2	54.8
HEXDC	FLJ23825	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 30.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center, Mitochondria"		"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.52e-5)"	12.7	8.5	7.1	16.6	9.3	14.3	8.7	13.2	7.3	10.1	7.6	8.8	12.8	8.0	10.0	11.1	7.9	10.3	9.4	5.7	7.2	4.6	9.9	11.6	12.4	11.6	12.8	5.5	13.6	72.9	10.2	14.6	5.7	7.4	14.1	4.2	7.0	13.3	9.2	20.4	11.3	12.3	6.0	6.1	15.6	8.8	4.7	11.4	8.6	11.7	8.6	10.7	8.3	8.8	5.9	30.3	3.3	11.5	11.9	9.8	4.4	3.0	7.7	3.4	5.3	10.4	9.0	10.5	3.9	4.8	4.1	4.7	2.7	10.4	8.1	4.3	1.6	2.8	4.3	2.0	2.3	1.9	5.6	13.1	3.6	6.8	4.5	9.3	2.4	9.3	6.4	2.3	1.1	4.2	5.6	5.3	6.2	4.6	2.8	1.1	7.0	8.4	9.0	3.1	5.6	4.7	10.0	2.9	15.8	3.1	4.6	4.8	10.2	8.1	5.3	7.3	1.6	8.5	9.2	5.3	2.7	5.1	2.0	2.7	12.7	2.4	6.0	2.1	6.9	2.7	3.3	1.7	2.7	9.8	11.5	6.5	4.6	2.2	3.4	2.0	5.9	3.5	5.1	3.0	11.9	4.9	30.3	1.4	4.4	7.1	9.3	13.2	7.3	7.2	4.6	12.8	5.5	7.4	11.4	3.0	8.5	8.3	9.5	4.1	19.2	4.4	12.7	9.4	12.5	17.4	17.7	4.7	8.3	5.4	1.2	8.0	16.8	0.0	8.2	5.3	6.2	10.5	10.3	12.9	13.7	39.7	13.3	16.0	9.5	2.1	33.1	11.5	5.0	16.2	14.4	18.7	5.8	10.1	23.3	6.1	29.0	19.4	6.2	6.0	10.2	2.0	3.3	12.9	12.0	7.5
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177209-119349761	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.2"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 149.9;Hepatocytes: 232.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 60.3;Hep G2: 42.3;Karpas-707: 47.2;U-266/70: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"		NA	NA		390000000	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042"	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	41.8	19.8	5.8	10.5	17.4	8.1	32.2	1.5	7.9	12.3	23.3	3.2	3.6	17.4	11.3	12.0	10.6	9.5	22.0	10.4	5.0	3.3	23.4	74.2	16.4	16.8	2.8	5.7	10.3	22.0	3.4	6.4	26.1	3.7	14.7	9.9	10.5	41.0	5.3	7.1	9.6	36.3	19.7	3.5	20.9	10.0	8.7	3.7	8.8	15.2	10.3	9.1	21.2	36.4	1.4	5.5	6.0	1.1	1.9	4.7	0.6	0.0	0.0	0.7	0.0	60.3	26.7	1.4	1.4	8.8	1.1	2.7	4.1	0.5	9.0	0.0	5.5	14.2	0.1	1.6	0.0	1.4	13.3	4.1	7.5	0.8	42.3	6.0	0.0	3.8	18.2	1.1	9.0	5.5	4.8	0.7	2.6	26.0	47.2	8.5	1.2	0.3	0.0	0.5	4.1	2.1	2.5	0.9	13.6	2.9	7.4	3.0	4.5	0.0	0.1	0.0	1.9	2.2	1.0	5.2	3.7	3.4	6.9	3.3	63.8	9.0	17.8	10.9	0.1	2.2	6.0	0.6	2.0	2.4	1.1	4.7	1.4	1.3	1.3	0.6	0.9	0.8	1.9	3.8	1.9	0.9	5.5	1.4	0.6	5.8	17.4	1.5	7.9	5.0	3.3	2.8	5.7	3.7	3.7	8.9	36.6	18.6	5.7	28.2	18.6	3.9	45.9	8.1	11.4	101.2	0.0	4.7	5.0	5.1	149.9	42.5	42.8	23.3	32.8	8.0	90.1	5.0	3.5	232.5	81.6	0.0	46.1	103.7	76.4	24.4	24.5	57.9	27.0	6.4	55.5	1.3	20.9	14.4	3.9	32.2	4.7	6.5	18.1	2.1	3.9	24.3	5.1	26.1	11.5	7.6
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 122.4"	"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 201.3;Syncytiotrophoblasts: 318.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		1100000	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: AB_2683419"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	11.1	9.7	13.9	9.1	15.8	3.8	9.7	11.9	15.2	14.4	10.7	8.5	9.4	8.1	15.8	10.7	11.5	12.2	9.2	11.0	11.2	9.2	11.8	16.4	8.1	9.9	12.0	13.9	11.2	27.4	21.7	9.6	122.4	11.3	11.2	9.5	8.3	11.1	10.5	10.5	7.5	9.0	13.7	10.4	10.4	10.3	10.1	14.4	16.1	19.4	6.9	9.8	13.6	9.8	3.7	4.4	4.0	2.7	6.0	9.8	2.4	14.4	6.3	10.8	9.3	14.2	17.1	34.6	12.0	18.8	5.4	5.1	4.8	8.3	10.8	22.3	15.4	5.1	8.6	5.0	10.2	12.2	13.5	7.6	6.4	8.9	5.3	8.6	10.0	14.8	11.5	11.0	8.3	7.3	10.0	16.1	7.6	10.3	16.7	11.3	28.1	6.1	3.2	5.5	7.3	6.6	5.5	23.5	7.4	7.5	19.7	5.9	8.6	11.9	12.8	9.4	14.7	6.3	6.4	15.3	12.2	10.1	8.6	12.2	11.4	7.7	7.3	16.2	8.0	29.0	1.3	2.7	4.0	5.2	2.1	6.2	3.3	4.3	4.3	2.3	3.7	3.6	5.2	2.1	6.0	1.7	4.4	9.8	2.4	13.9	15.8	11.9	15.2	11.2	9.2	12.0	13.9	11.3	14.4	35.7	30.2	42.7	29.6	27.5	59.3	85.6	35.7	42.8	40.9	41.8	21.6	40.9	14.9	26.4	27.9	33.3	25.6	23.3	52.0	201.3	31.7	37.6	15.1	78.0	25.6	41.3	20.8	34.4	30.7	15.9	49.8	22.8	38.8	12.6	32.4	40.2	36.9	21.0	61.5	21.5	39.0	38.8	29.1	63.9	52.5	30.2	318.2	30.5	26.4	37.2
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086927-137109187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051516	Approved		Uncertain	Vesicles		NA	NA		540000	Vesicles		"HPA051516: AB_2681518"	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	20.4	25.4	19.7	13.5	23.7	9.8	18.6	21.6	36.1	24.3	21.6	24.5	20.6	19.8	22.7	28.1	23.1	28.9	25.9	19.5	20.5	21.5	24.3	32.7	20.4	19.9	18.6	25.2	24.2	32.6	23.6	25.1	30.8	18.0	21.2	12.0	22.0	32.7	23.1	12.2	25.4	17.8	18.5	16.4	22.2	21.8	30.3	18.2	19.9	25.1	12.7	19.3	21.0	16.0	13.0	23.0	16.3	24.4	18.0	21.9	18.5	7.2	17.1	6.0	16.9	22.5	19.4	19.8	12.4	26.2	16.5	14.7	8.4	22.9	6.6	41.5	20.6	23.3	25.1	3.6	12.0	3.0	9.1	6.0	2.9	15.4	9.6	21.3	5.1	11.4	22.9	22.7	9.6	8.1	22.1	10.9	8.9	8.0	10.9	11.7	14.7	5.4	12.1	8.0	21.4	17.3	3.1	10.0	20.9	13.2	3.6	6.9	6.2	18.3	19.4	12.6	3.2	21.6	10.9	15.3	24.5	9.1	18.0	14.4	4.4	3.6	4.4	29.4	6.5	21.0	7.9	20.1	16.3	21.9	21.8	20.5	13.0	17.3	20.6	23.0	11.0	17.0	17.0	5.9	18.0	24.4	16.1	21.5	18.5	19.7	23.7	21.6	36.1	20.5	21.5	18.6	25.2	18.0	18.2	17.9	33.0	15.9	12.9	10.3	17.8	9.3	15.3	16.0	7.9	24.4	15.7	44.1	6.6	27.3	4.5	16.8	31.6	0.0	27.7	61.8	26.8	11.6	20.7	17.9	29.2	28.6	29.2	17.8	16.4	4.3	19.5	16.3	21.9	33.3	26.3	17.7	26.2	24.6	20.5	13.0	18.2	12.9	16.0	15.6	26.2	14.2	38.0	24.5	21.3	6.8
MAN1C1	HMIC	ENSG00000117643	"Mannosidase alpha class 1C member 1"	Q9NR34	1	25617468-25786207	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 51.1;Ito cells: 82.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"AF22: 12.7;HSkMC: 47.0;U-266/70: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048352	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA		1200000	"Nucleoplasm, Vesicles"		"HPA048352: AB_2680368"	"unprognostic (2.75e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.18e-2)"	4.6	4.5	4.2	3.0	3.8	0.0	2.2	9.9	8.8	8.6	3.6			1.2	6.6	2.5	2.4	3.9	7.3	3.4	5.2	3.2	10.3	12.1	3.2	4.0	4.2		7.1	0.7	4.4	7.8	8.3		7.2	1.2		1.8	7.5	0.9	2.7	1.9	8.0	6.0	7.0	3.1	1.0			10.7		3.2	4.3	4.0	1.0	0.6	1.1	1.6	0.8	8.3	1.1	0.0	0.1	12.7	2.7	9.5	7.4	3.7	0.1	2.4	0.6	0.2	0.2	0.0	0.1	0.1	0.9	1.7	0.1	1.2	0.1	0.2	4.0	0.5	0.2	0.2	0.0	1.1	2.1	5.3	47.0	0.2	0.2	0.0	0.2	0.0	0.5	0.0	0.5	0.0	0.6	0.0	2.3	3.3	0.0	0.1	0.2	7.8	0.2	0.1	0.2	7.5	0.2	0.3	2.0	0.6	2.4	1.0	1.5	0.0	0.0	0.7	8.6	0.3	14.0	0.0	0.0	1.9	4.5	0.6	0.4	1.6	0.7	0.6	1.0	0.8	0.4	3.6	1.6	0.6	1.0	8.3	4.8	1.1	0.8	1.3	0.4	0.8	1.1											3.0	2.7	1.9	2.9	6.0	19.1	6.4	5.1	2.7	7.9	21.0	51.1	8.3	8.3	0.5	0.3	11.1	0.0	0.0	3.4	1.0	9.9	2.6	2.3	37.6	19.1	20.6	2.9	82.9	16.5	0.9	25.0	3.6	1.7	0.0	0.0	20.6	2.2	0.0	20.8	12.8	4.5	6.5	3.1	0.2	2.0	4.5	35.7	5.3	0.0	1.3
MAN2A1	"GOLIM7, MANA2"	ENSG00000112893	"Mannosidase alpha class 2A member 1"	Q16706	5	109689366-109869625	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.8"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 88.9;Hepatocytes: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022377, HPA026896"	Enhanced		Supported	"Golgi apparatus"		NA	NA		70000000	"Golgi apparatus"		"CAB022377: , HPA026896: AB_1853512"	"unprognostic (1.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.31e-3)"	7.6	17.5	10.9	7.7	21.8	5.7	7.4	1.9	13.2	8.4	11.2	46.8	2.4	17.2	9.2	1.8	7.7	6.2	10.6	4.2	11.7	4.8	9.5	20.7	8.5	7.8	29.9	10.4	7.5	16.7	20.1	3.4	8.7	19.8	4.7	11.9	5.6	9.0	6.0	8.7	7.0	14.4	11.2	23.1	6.9	8.9	7.5	30.6	15.0	9.0	1.8	7.8	10.9	6.2	3.3	2.7	5.8	6.7	0.9	5.5	1.6	7.3	6.8	8.5	3.6	16.4	14.5	32.0	16.4	27.1	9.3	16.9	8.0	11.9	5.3	10.6	21.3	6.5	8.7	4.5	17.0	20.5	5.7	3.5	10.8	5.1	7.3	9.2	4.9	5.9	12.3	7.0	14.9	19.9	11.5	18.4	5.4	2.9	31.1	22.0	3.6	9.1	1.3	6.1	4.9	2.5	3.6	13.3	23.5	7.5	11.7	1.2	1.1	7.7	6.9	4.6	9.6	6.8	4.3	19.6	18.5	8.2	10.0	10.6	16.6	21.5	4.5	14.2	6.3	10.2	5.8	2.9	0.9	3.0	3.8	1.9	3.3	4.5	4.9	2.7	2.9	5.5	4.8	2.1	0.9	6.7	2.5	4.1	1.6	10.9	21.8	1.9	13.2	11.7	4.8	29.9	10.4	19.8	30.6	6.0	6.7	28.2	9.3	15.9	0.2	5.9	40.8	9.4	7.9	29.6	0.0	16.0	1.7	21.5	7.3	22.4	45.5	23.3	30.1	88.9	21.8	26.3	14.0	113.4	16.8	0.0	23.7	41.7	62.5	4.9	9.2	22.8	25.3	25.2	37.1	7.5	30.3	28.1	6.3	21.4	0.3	19.4	16.0	5.5	19.1	20.7	19.8	15.8	41.2	17.8
MAN2A2	"HsT19662, MANA2X"	ENSG00000196547	"Mannosidase alpha class 2A member 2"	P49641	15	90902218-90922584	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.4;neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077930			Approved	"Cytoplasmic bodies"		NA	NA		30000000	"Cytoplasmic bodies"		"HPA077930: AB_2732363"	"unprognostic (5.17e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (7.55e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.33e-2)"	17.8	12.1	15.9	11.5	24.3	58.1	17.3	33.7	31.2	7.2	9.9	52.4	6.3	12.0	8.9	9.8	7.6	8.0	9.4	22.7	17.8	14.0	8.1	16.7	13.3	12.4	31.6	19.7	9.7	24.0	13.0	15.2	12.4	31.0	9.2	9.0	17.2	20.6	12.6	41.8	14.8	13.0	7.6	33.1	19.1	12.4	12.7	28.3	3.8	13.8	2.7	9.1	7.5	10.7	1.5	2.1	10.0	3.2	0.1	1.4	1.5	5.8	6.1	4.3	10.2	13.0	3.5	8.4	4.3	3.9	4.5	3.5	4.9	4.4	0.8	10.6	5.0	4.1	6.7	4.5	2.5	2.8	14.5	10.6	40.0	9.2	3.3	4.3	5.8	21.7	2.5	4.7	5.4	4.4	9.0	5.9	10.7	15.0	5.3	2.0	7.9	3.8	11.6	1.4	9.7	1.9	5.2	4.1	6.1	5.6	14.1	10.4	6.0	5.9	11.1	8.4	4.5	5.2	19.1	5.0	3.7	4.0	4.5	5.6	8.1	24.9	2.1	4.3	8.5	6.2	8.4	1.6	0.6	1.4	1.1	0.9	1.0	0.6	0.8	0.3	1.5	0.4	0.4	10.0	0.1	3.2	2.1	1.3	1.5	15.9	24.3	33.7	31.2	17.8	14.0	31.6	19.7	31.0	28.3	11.9	23.5	5.6	2.9	5.4	24.8	12.6	7.6	5.3	10.3	8.7	25.5	7.3	0.0	3.9	5.9	7.9	8.1	23.3	5.6	1.8	6.4	5.8	15.1	19.2	5.4	23.8	4.1	7.4	12.2	5.2	6.4	13.5	28.7	10.0	7.2	18.0	4.1	5.7	4.6	3.0	69.2	12.9	8.5	8.8	6.1	4.1	6.3	8.7	7.9	3.0
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Macrophages: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 41.9;monocytes: 42.1"	"Low cell line specificity"	"Detected in all"											"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3400000	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	25.2	15.6	7.9	26.7	11.0	33.4	24.4	4.4	7.0	10.5	15.0	14.0	8.6	14.2	15.3	16.5	12.2	13.4	16.4	19.4	6.4	4.4	13.6	16.3	30.2	68.6	10.0	4.7	12.2	21.7	9.1	7.2	15.8	8.6	13.7	10.6	12.0	22.0	8.1	7.7	18.0	20.0	10.2	11.7	51.3	19.5	6.3	8.2	22.1	11.3	7.8	30.0	18.7	11.2	7.7	41.9	6.5	42.1	2.7	8.4	26.0	16.5	8.5	8.7	10.2	29.0	19.5	24.6	12.3	26.0	11.0	10.8	6.8	7.0	18.2	15.0	9.7	3.1	13.0	4.4	8.2	5.3	9.0	13.5	6.3	4.2	11.0	14.8	41.5	43.3	23.2	16.2	6.1	7.8	11.9	10.4	6.9	8.0	13.8	5.8	12.9	5.6	23.4	7.2	8.3	10.8	13.0	11.9	9.0	13.0	19.2	2.7	8.5	12.2	10.5	20.0	5.5	16.2	25.7	13.6	15.0	6.2	14.5	11.5	18.4	20.2	9.0	10.1	40.9	16.7	2.2	42.1	6.2	7.5	39.4	8.4	7.7	6.9	6.7	35.2	6.5	3.8	3.8	6.5	2.7	28.4	41.9	6.8	26.0	7.9	11.0	4.4	7.0	6.4	4.4	10.0	4.7	8.6	8.2	6.0	6.9	14.4	1.6	3.2	2.6	0.7	2.5	5.3	1.2	1.8	0.0	2.0	1.7	1.6	2.0	1.0	2.5	23.3	2.0	2.3	2.8	2.2	1.1	0.8	7.9	0.0	1.7	2.5	10.2	8.1	3.4	18.6	1.7	5.4	0.9	1.3	1.0	2.9	4.2	1.1	3.0	12.9	1.2	0.5	1.5	2.9	2.3	5.4	1.7	1.6
MAN2B2	KIAA0935	ENSG00000013288	"Mannosidase alpha class 2B member 2"	Q9Y2E5	4	6575175-6623362	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		11000000				"unprognostic (1.30e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.18e-1)"	21.3	15.4	12.4	15.6	23.2	15.7	16.7	5.1	26.8	17.3	14.3	16.2	12.1	15.9	20.0	21.5	13.9	18.1	24.7	23.2	11.6	14.2	15.8	32.4	20.1	19.4	13.7	11.4	30.4	26.0	10.8	19.2	17.0	14.3	20.6	9.8	22.2	18.6	15.2	7.8	13.5	15.9	14.5	11.6	19.7	20.9	8.7	13.4	16.6	27.3	10.4	18.4	20.7	20.7	5.0	8.4	13.4	15.7	6.0	12.0	9.1	8.1	7.4	1.6	10.1	22.3	15.5	9.6	16.8	19.6	8.2	11.3	4.3	15.5	4.1	8.1	18.1	19.3	8.3	0.5	5.3	4.5	4.8	4.2	5.4	5.4	4.8	9.8	10.2	25.4	20.4	5.3	6.5	1.8	14.9	9.5	5.3	2.3	10.6	10.6	5.0	5.0	6.5	1.8	10.3	5.7	5.0	7.0	4.8	4.3	8.2	2.5	2.7	11.2	6.7	4.3	5.2	13.4	13.8	17.3	15.0	4.6	18.6	10.5	4.4	3.8	2.2	17.5	12.0	12.8	13.1	8.5	13.4	12.0	13.0	9.3	4.4	7.4	10.9	8.4	5.0	6.9	8.7	10.7	6.0	15.7	3.2	10.1	9.1	12.4	23.2	5.1	26.8	11.6	14.2	13.7	11.4	14.3	13.4	14.9	20.5	11.5	3.9	4.4	9.1	14.7	22.9	10.7	13.6	10.4	5.9	9.9	1.7	8.9	0.4	7.3	11.9	0.0	9.3	7.5	10.1	7.8	10.4	36.3	17.8	9.5	7.5	12.3	27.8	0.0	18.1	10.4	3.3	3.6	8.7	12.1	9.5	7.0	23.0	3.7	6.8	12.9	7.3	0.9	0.7	3.3	7.1	10.9	6.6	3.7
MAN2C1	"MANA, MANA1"	ENSG00000140400	"Mannosidase alpha class 2C member 1"	Q9NTJ4	15	75355207-75368630	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040627, HPA067407"	Uncertain		Enhanced	Nucleoplasm		NA	NA		9000	Nucleoplasm		"HPA040627: AB_10795490, HPA067407: AB_2685834"	"unprognostic (4.68e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-3)"	29.9	28.8	22.6	20.4	26.0	30.0	24.6	27.5	25.5	25.1	25.1	26.8	23.8	22.9	27.8	27.5	20.2	24.2	23.3	28.2	18.3	12.9	22.9	21.4	25.2	17.0	23.0	28.3	32.8	22.3	28.2	30.6	22.4	18.3	24.9	14.2	30.8	25.6	20.2	37.9	30.9	27.7	20.0	15.0	28.1	23.0	28.8	19.9	21.0	34.7	15.3	19.5	21.1	21.3	2.3	15.7	2.6	16.2	3.9	7.3	8.5	5.5	13.3	11.1	8.0	12.7	11.0	13.8	12.9	12.2	6.8	5.7	9.2	19.1	2.7	7.6	9.4	6.2	17.2	6.1	8.7	4.4	15.2	13.4	17.5	25.2	9.1	18.8	11.2	2.8	13.1	8.8	6.4	8.1	14.4	15.8	8.0	10.0	14.4	5.5	10.8	5.5	12.7	4.7	6.6	5.6	7.8	5.6	16.6	8.9	25.9	6.6	12.0	8.2	12.5	5.8	8.3	12.4	13.1	30.9	14.3	10.0	9.9	12.7	14.4	3.5	4.4	9.2	12.9	14.2	2.6	13.3	2.0	7.2	16.2	6.8	2.3	5.3	5.2	15.7	2.0	7.3	5.1	1.4	3.9	12.4	6.4	7.0	8.5	22.6	26.0	27.5	25.5	18.3	12.9	23.0	28.3	18.3	19.9	20.8	52.5	12.9	13.4	11.9	32.1	2.0	5.1	16.0	18.2	8.7	51.1	14.5	3.3	9.4	8.2	17.2	21.3	0.0	7.7	8.8	15.0	13.8	31.1	21.5	17.5	27.0	32.8	33.2	37.8	10.6	21.6	24.1	15.1	19.8	21.0	18.6	9.2	14.4	11.7	12.3	52.0	25.8	10.4	18.6	10.9	7.4	17.7	12.7	20.7	11.9
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		12000000	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	12.7	23.5	8.5	12.2	11.9	8.6	17.1	13.4	8.4	12.1	9.9	12.9	11.7	8.1	11.6	13.6	9.3	11.0	15.5	12.1	8.7	8.6	11.8	10.3	17.7	20.2	15.1	6.2	16.7	18.1	25.1	18.4	25.0	10.8	12.0	10.8	12.4	27.4	11.4	5.4	7.8	14.0	14.2	15.3	21.3	14.4	4.6	13.5	9.4	19.2	3.6	12.8	17.9	12.6	3.9	9.5	25.2	11.6	3.6	3.1	3.9	7.0	3.9	1.9	1.9	37.5	17.4	4.9	4.9	9.7	2.1	4.2	5.1	8.2	7.6	6.6	6.8	6.8	3.3	5.0	10.8	1.7	5.3	2.1	4.3	4.5	7.8	11.4	8.0	19.6	14.8	18.5	9.1	7.6	27.8	3.9	3.3	7.2	7.8	7.7	3.2	1.9	7.7	2.7	8.7	3.2	3.9	4.5	2.1	6.1	8.3	1.2	0.9	5.8	10.1	7.6	20.0	14.4	5.5	3.0	5.8	2.8	13.0	2.6	4.2	8.7	0.7	10.5	3.6	4.2	6.2	11.5	25.2	1.8	10.6	1.4	3.8	3.1	2.0	9.5	3.9	3.0	2.0	10.1	3.6	11.6	2.3	1.6	3.9	8.5	11.9	13.4	8.4	8.7	8.6	15.1	6.2	10.8	13.5	29.8	35.2	25.3	8.3	5.3	5.4	10.4	12.7	4.0	12.5	8.7	5.9	32.0	1.7	5.7	1.9	7.2	4.6	0.0	2.4	6.3	10.6	7.4	33.5	15.8	38.4	6.4	1.7	9.2	46.4	1.1	8.3	42.8	0.0	29.7	10.9	4.3	5.7	21.0	18.7	7.6	7.1	0.0	8.3	0.2	1.1	4.0	18.9	10.9	10.5	8.3
MGAT1	"GLCNAC-TI, GLYT1, GNT-1, GnTI, MGAT"	ENSG00000131446	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase"	P26572	5	180784782-180815652	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 254.2;Syncytiotrophoblasts: 321.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017432	Approved					NA	NA		7200000			"HPA017432: AB_1853851"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (4.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.00e-2)"	67.7	20.9	14.9	30.8	20.1	25.5	53.3	15.6	19.3	22.3	29.0	14.6	22.4	24.8	26.1	26.8	31.2	26.4	19.8	26.4	16.1	10.6	20.8	55.6	42.7	50.5	25.6	10.3	27.2	37.1	8.5	20.8	84.9	17.7	26.6	15.3	24.1	28.4	21.8	18.5	22.9	35.1	20.7	31.1	45.7	24.5	19.2	21.9	27.0	32.1	16.9	29.8	38.2	39.1	13.2	40.8	37.7	54.9	16.5	24.9	47.2	14.3	14.4	7.9	17.0	42.0	19.2	27.8	34.2	42.1	21.5	26.9	20.6	11.8	12.3	19.3	33.0	20.8	17.2	4.2	51.0	12.7	66.0	11.9	10.8	8.3	15.9	20.4	9.8	35.4	22.2	24.5	17.3	17.3	14.1	18.6	8.5	6.2	22.1	19.2	20.3	9.2	14.1	7.7	9.4	18.6	11.3	11.7	16.1	8.2	17.1	6.8	8.2	14.3	14.8	28.2	7.3	11.4	17.6	19.9	26.2	11.7	11.2	15.4	41.8	34.5	10.8	21.3	20.0	13.2	19.5	54.9	25.3	22.4	45.9	24.9	13.2	16.4	18.7	40.8	12.1	14.4	16.0	37.7	16.5	35.1	38.9	18.8	47.2	14.9	20.1	15.6	19.3	16.1	10.6	25.6	10.3	17.7	21.9	44.7	30.3	44.7	32.3	54.4	15.3	16.2	33.1	10.7	10.3	27.9	53.0	78.1	31.5	43.2	24.8	80.8	40.7	46.7	68.5	254.2	87.6	52.3	30.0	71.9	181.6	60.4	47.8	132.0	151.5	31.6	58.1	136.4	77.6	84.8	43.1	15.3	50.1	31.6	71.5	17.0	77.1	32.3	55.2	18.4	19.0	55.8	321.9	60.9	34.7	55.2
MGAT2	GNT-II	ENSG00000168282	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase"	Q10469	14	49620795-49623481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043721, HPA056824"	Approved		Supported	"Golgi apparatus"		NA	NA		5000000	"Golgi apparatus"		"HPA043721: AB_2678636, HPA056824: AB_2683248"	"unprognostic (1.20e-2)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (2.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	14.0	17.0	7.4	14.0	7.1	5.0	12.3	7.3	8.4	11.7	16.5	7.8	16.5	13.9	12.9	14.1	11.7	11.4	16.8	10.1	6.2	6.6	13.2	34.4	10.3	20.5	6.1	7.2	15.3	27.9	4.8	8.2	14.1	5.8	9.4	13.7	10.7	34.9	19.1	5.1	6.3	29.1	9.7	7.1	20.9	12.3	27.7	5.8	18.2	9.0	7.2	14.8	11.6	9.1	15.5	28.2	22.1	22.8	12.0	24.7	23.2	18.9	9.4	7.2	12.2	17.2	16.8	4.7	21.1	21.0	19.6	17.7	11.4	14.5	19.3	18.0	19.2	11.3	15.2	10.2	12.2	21.2	19.6	9.0	12.3	7.0	11.2	13.6	28.1	28.8	12.8	9.8	11.6	16.5	14.4	23.4	9.7	9.4	53.3	20.6	7.2	9.7	18.0	7.4	6.7	15.2	11.0	21.1	16.6	15.3	11.1	7.5	8.1	15.1	4.0	11.9	7.3	12.2	19.3	24.2	17.8	19.3	12.9	15.0	57.7	27.6	17.2	8.6	14.1	11.9	21.7	22.8	22.1	23.0	20.0	24.7	15.5	21.3	20.7	23.6	10.4	12.6	17.3	6.8	12.0	21.6	28.2	18.2	23.2	7.4	7.1	7.3	8.4	6.2	6.6	6.1	7.2	5.8	5.8	11.9	10.4	19.4	21.6	14.0	13.0	0.0	30.6	6.7	5.7	10.4	3.9	22.7	8.3	27.1	6.0	17.8	21.0	0.0	30.2	35.1	27.8	21.6	16.2	45.1	33.0	17.5	11.6	23.9	33.8	4.6	16.1	22.6	20.3	37.9	18.9	14.9	29.0	23.0	20.8	12.2	14.8	6.5	16.7	40.5	12.8	12.3	4.5	33.7	19.6	25.3
MGAT3	GNT-III	ENSG00000128268	"Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase"	Q09327	22	39457344-39492194	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0;intestine: 27.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 41.7;Bipolar cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.5;eosinophil: 3.3;memory B-cell: 1.7;naive B-cell: 1.2"	"Group enriched"	"Detected in many"	9	"B-cells: 1.7;granulocytes: 3.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 28.1;HMC-1: 24.3;OE19: 24.3;U-266/70: 31.6;U-266/84: 12.8;U-698: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017598	Approved				"Intracellular and membrane"	NA	NA		78000			"HPA017598: AB_1853853"	"unprognostic (1.41e-3)"	"unprognostic (5.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.71e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.35e-3)"	"unprognostic (6.77e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (5.04e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.92e-2)"	5.3	1.2	17.1	3.9	18.7	9.2	3.6	29.0	24.6	7.1	11.9	8.9	0.0	21.1	3.4	1.2	1.4	4.0	7.9	3.0	18.1	14.9	3.3	0.4	14.9	7.2	13.1	13.4	1.0	3.1	0.9	1.4	10.5	10.7	1.0	4.9	1.7	2.1	1.4	1.6	2.5	27.1	3.2	10.4	3.3	7.8	4.9	9.0	0.2	1.1	0.0	8.9	3.0	2.7	1.7	0.1	3.5	0.2	0.0	0.2	0.1	0.1	0.1	4.6	0.4	0.0	0.0	28.1	0.2	0.3	0.2	0.0	6.2	1.5	9.7	3.4	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.2	7.8	0.0	0.0	0.1	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.4	1.2	0.0	0.1	0.2	0.6	1.3	24.3	0.0	0.4	0.0	1.6	0.2	0.2	2.6	1.9	0.0	0.0	0.0	8.4	0.3	0.4	0.0	0.0	3.7	0.0	0.0	31.6	12.8	13.7	0.0	0.0	0.7	3.5	0.1	3.3	0.1	0.2	0.1	1.7	0.0	0.0	0.1	1.2	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.1	17.1	18.7	29.0	24.6	18.1	14.9	13.1	13.4	10.7	9.0	41.7	4.0	3.7	0.1	0.3	30.0	1.2	2.5	2.7	1.2	0.0	5.9	4.6	0.0	0.0	11.0	2.3	5.2	0.0	0.2	10.1	0.6	0.0	2.3	0.0	1.3	12.7	7.5	0.0	0.0	16.2	4.0	0.7	0.0	0.0	3.2	1.5	1.3	3.4	3.5	1.3	2.3	6.5	1.4	0.7	1.0	0.5	3.1	0.9	3.4	1.3
MGAT4A	"GnT-4a, GnT-Iva"	ENSG00000071073	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A"	Q9UM21	2	98619106-98731126	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 46.0;HUVEC TERT2: 17.2;JURKAT: 30.7;TIME: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007608	Enhanced		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"HPA007608: AB_10602008"	"prognostic unfavorable (4.30e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.48e-8)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.04e-1)"	8.1	5.1	11.3	11.9	15.6	49.2	8.2	28.5	14.3	6.1	14.6	8.3	6.8	17.6	5.2	4.1	4.1	6.2	8.0	5.1	11.3	10.4	17.1	6.0	13.7	16.7	9.9	8.3	2.9	26.7	33.3	14.1	11.9	10.4	6.6	15.8	5.6	14.5	4.4	3.3	3.4	38.5	7.2	16.1	7.0	8.4	3.9	14.3	20.3	6.4	3.1	11.6	8.3	5.0	2.0	9.3	7.6	2.9	7.7	19.7	7.4	3.0	0.6	1.2	2.6	0.0	0.0	46.0	0.0	0.0	0.3	0.0	7.3	3.7	0.0	6.9	0.0	0.9	0.1	2.5	0.3	0.0	3.6	2.8	0.1	0.0	12.7	0.0	6.1	2.3	0.0	1.7	0.0	0.2	0.1	17.2	30.7	0.5	3.3	0.0	5.9	13.3	10.7	0.4	2.6	0.5	3.3	0.0	3.6	8.9	6.2	3.7	1.2	0.8	11.5	1.6	3.4	2.7	8.3	27.8	0.0	1.4	0.0	0.9	1.1	2.5	0.7	0.0	9.2	0.2	3.3	2.9	6.6	12.3	0.5	15.9	2.0	14.9	13.7	2.0	1.1	19.7	16.1	7.6	7.7	1.1	9.3	8.4	7.4	11.3	15.6	28.5	14.3	11.3	10.4	9.9	8.3	10.4	14.3	50.6	31.3	18.2	18.4	8.9	20.9	11.7	10.2	5.3	13.6	21.0	3.9	3.9	18.3	15.5	10.0	32.8	84.5	0.0	25.8	66.5	5.4	17.8	12.7	8.5	53.2	46.1	50.8	20.3	30.7	13.9	2.3	33.8	10.1	10.0	34.5	13.6	22.1	48.9	2.1	25.6	4.8	6.5	5.1	2.8	3.4	9.3	12.5	74.0	30.1	20.1
MGAT4B	GnT-Ivb	ENSG00000161013	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B"	Q9UQ53	5	179797597-179806952	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 125.6;liver: 100.0"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 212.8;Paneth cells: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"eosinophil: 8.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012804, HPA052134"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles, Cytosol"	"HPA012804: , HPA052134: AB_2681741"	"unprognostic (2.01e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (3.61e-3)"	"unprognostic (7.57e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.42e-1)"	13.2	22.8	9.1	19.5	8.2	9.5	18.7	15.3	13.5	8.7	77.3	5.9	10.1	61.7	9.2	10.4	16.8	10.7	26.0	20.6	9.5	5.4	31.9	100.0	17.1	15.6	6.3	5.2	9.1	13.4	10.3	8.3	14.4	6.3	8.8	30.9	10.1	19.2	8.2	8.4	12.1	125.6	7.5	4.9	12.5	22.3	11.2	5.6	7.0	16.6	14.6	10.0	9.5	13.7	0.9	0.6	8.5	0.7	0.0	0.6	0.2	20.8	21.1	10.4	24.1	32.0	17.2	18.1	12.4	24.9	11.3	8.9	23.1	58.2	3.5	31.9	28.6	50.4	15.8	15.2	27.9	8.6	29.2	8.1	10.7	19.2	20.1	22.6	13.5	3.3	18.6	19.6	11.5	14.3	44.4	23.2	4.2	6.9	9.6	19.0	23.3	2.0	11.2	6.4	31.9	8.5	5.2	8.3	9.9	33.9	40.6	17.2	10.1	18.6	19.3	33.4	9.2	13.2	13.7	28.3	28.6	12.7	16.0	19.8	8.2	9.4	8.8	34.3	17.0	20.6	0.0	0.7	8.5	0.3	0.1	0.1	0.0	0.5	0.2	0.6	0.9	0.4	0.6	0.3	0.0	0.5	0.5	0.0	0.2	9.1	8.2	15.3	13.5	9.5	5.4	6.3	5.2	6.3	5.6	11.9	8.6	8.5	16.0	11.1	15.5	21.6	25.5	0.0	5.7	26.2	3.9	6.8	3.3	60.0	0.5	14.3	212.8	0.0	46.0	9.9	10.4	29.2	4.7	75.0	15.1	28.6	22.0	31.9	17.0	1.6	14.1	11.7	10.1	18.0	64.6	23.5	79.0	114.3	15.9	20.7	10.4	12.9	8.6	1.6	4.8	10.5	11.7	5.0	102.6	39.7
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 99.1;Late spermatids: 74.0"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 11.0;SCLC-21H: 4.8;SuSa: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016418	Approved		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Vesicles, Plasma membrane"	"Centriolar satellite"	"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	1.0	3.0	5.5	1.0	12.3	1.1	0.9	4.9	12.8	1.3	1.2	2.5	0.4	0.9	1.0	10.9	1.1	1.1	1.2	3.6	9.4	3.9	1.0	0.9	1.0	0.9	3.0	9.3	0.9	0.9	0.9	25.9	0.8	10.6	1.1	1.2	0.0	0.9	2.4	0.8	1.0	1.0	1.0	4.3	0.9	1.0	7.8	5.1	0.0	18.0	0.0	0.8	0.9	0.6	0.5	0.3	0.8	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	11.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.8	0.2	0.1	0.3	0.2	0.0	5.5	12.3	4.9	12.8	9.4	3.9	3.0	9.3	10.6	5.1	6.0	0.6	0.0	0.1	0.1	9.7	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.1	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	74.0	15.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	3.9	0.0	1.6	0.0	0.0	1.7	0.6	0.1	0.0	0.0	0.0	0.3
MGAT5	GNT-V	ENSG00000152127	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase"	Q09328	2	134119983-134454621	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010919	Approved					NA	NA		96000			"HPA010919: AB_10601864"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.45e-3)"	"unprognostic (3.41e-3)"	"unprognostic (5.68e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-1)"	8.4	9.8	13.0	21.7	15.7	12.0	8.0	21.3	17.6	9.0	13.2	17.2	4.6	14.2	8.5	6.3	8.2	17.5	15.1	33.9	13.9	17.5	14.3	4.9	9.3	20.1	23.6	11.6	11.3	11.1	18.8	7.9	22.0	28.0	7.9	13.8	8.3	11.9	9.1	3.2	6.6	19.2	10.1	28.7	23.1	15.0	6.6	13.2	16.5	10.3	5.1	28.9	11.0	9.2	7.5	1.8	2.3	0.8	2.4	3.1	1.1	10.2	4.1	10.5	7.5	9.4	18.0	7.3	13.7	20.9	5.5	4.7	1.7	5.1	16.5	10.5	10.9	6.3	3.6	8.2	6.4	10.7	16.1	4.8	9.2	5.3	21.4	6.1	8.9	32.9	4.9	6.7	11.6	7.2	7.5	41.3	8.3	4.7	11.3	10.0	6.6	4.8	4.2	4.8	10.7	10.2	6.0	12.4	10.3	4.3	12.6	17.4	21.4	4.4	3.8	26.1	7.4	2.9	6.2	18.6	17.5	9.3	12.7	7.1	3.2	1.5	6.2	14.7	12.8	27.8	1.2	0.7	1.8	1.6	0.7	2.7	5.6	3.1	2.1	0.6	7.5	1.3	1.6	2.3	2.4	0.8	1.8	1.9	1.1	13.0	15.7	21.3	17.2	13.9	17.5	23.6	11.6	28.0	13.2	3.0	3.7	22.6	5.1	7.1	27.7	52.8	5.1	13.4	3.4	1.8	2.0	3.0	0.0	8.0	14.2	11.6	18.6	0.0	7.8	24.2	4.1	7.5	0.0	2.9	12.9	15.9	6.9	11.1	12.7	10.6	4.0	7.3	13.5	1.8	17.2	8.8	10.4	14.2	8.9	2.1	4.7	0.0	11.8	0.3	7.0	6.4	4.5	10.2	9.4	13.2
MOGS	"CWH41, DER7, GCS1"	ENSG00000115275	"Mannosyl-oligosaccharide glucosidase"	Q13724	2	74461057-74465410	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Late spermatids: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011322, HPA011969"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		88000000	"Endoplasmic reticulum"		"HPA011322: AB_2668483, HPA011969: AB_1849579"	"unprognostic (5.66e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (1.48e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.36e-1)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	15.8	12.8	8.7	15.2	10.6	8.5	13.1	11.3	12.1	13.9	19.4	10.8	24.9	36.5	14.2	15.8	15.5	13.4	16.4	11.2	7.7	6.1	14.8	40.5	17.2	15.6	9.2	7.9	14.2	30.6	20.4	15.7	35.8	8.3	15.9	11.2	11.7	24.5	25.3	14.1	17.4	35.8	9.8	7.1	22.4	22.3	11.9	8.1	17.6	18.9	11.4	19.5	14.1	12.9	3.9	3.4	2.3	4.4	12.7	5.1	2.5	22.2	19.8	13.1	12.6	27.1	19.2	40.3	18.2	26.5	27.7	26.7	36.2	23.8	24.1	16.3	18.4	20.8	22.4	19.8	20.6	17.2	20.8	19.2	11.3	12.8	27.7	22.4	26.4	22.7	11.2	33.0	19.6	19.2	30.9	31.0	14.3	19.6	23.4	12.2	27.7	14.3	20.3	17.3	28.2	11.0	16.4	29.3	31.2	15.1	13.8	10.8	14.2	8.7	36.3	23.7	13.0	17.5	14.2	22.1	12.8	22.3	18.5	24.1	36.2	14.9	10.7	20.1	21.6	17.3	2.3	4.0	1.1	5.0	2.5	5.1	2.5	4.2	4.5	3.4	3.9	3.7	2.4	0.7	12.7	4.4	3.2	3.8	2.5	8.7	10.6	11.3	12.1	7.7	6.1	9.2	7.9	8.3	8.1	6.0	15.7	9.0	17.4	14.1	14.2	5.8	15.3	9.4	12.5	22.7	17.7	32.9	5.0	19.7	52.1	10.9	21.0	23.3	22.8	34.8	8.7	19.5	4.6	22.1	17.5	6.4	13.4	17.8	7.9	186.6	14.1	16.0	10.1	27.1	24.4	8.3	19.0	20.3	6.7	8.4	12.7	12.9	7.6	8.6	3.2	15.2	43.5	14.0	17.9	17.3
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		86000	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	10.5	30.2	8.6	9.4	11.1	5.2	10.5	15.5	14.6	13.4	14.1	7.4	16.1	14.1	9.8	13.9	9.0	8.3	16.1	9.8	8.0	9.5	29.7	24.2	16.1	7.2	9.4	6.6	12.7	20.6	13.6	16.5	19.8	10.3	15.1	9.1	14.7	18.1	13.8	10.0	9.1	23.5	9.8	4.7	13.4	12.7	6.5	10.0	5.8	22.7	7.0	9.6	13.6	9.5	4.2	7.7	15.2	13.4	3.0	5.1	7.4	2.4	2.4	2.4	5.6	8.2	3.1	4.8	2.2	7.5	6.5	9.6	14.1	2.6	0.8	5.7	2.9	38.4	1.3	5.1	2.0	2.5	2.0	3.4	1.2	1.4	16.5	14.7	1.5	6.9	5.1	3.8	7.9	4.1	3.9	5.8	1.6	2.6	5.8	3.3	4.3	1.2	2.3	1.9	4.3	1.9	1.7	1.3	8.5	10.8	5.2	1.8	1.1	2.4	3.3	5.8	3.2	6.2	7.1	2.4	4.3	2.5	6.0	3.9	7.2	11.5	1.7	3.1	3.9	3.0	6.4	13.4	8.7	5.1	10.3	4.2	3.9	3.9	4.1	7.7	4.2	4.0	3.9	15.2	3.0	9.2	4.3	4.8	7.4	8.6	11.1	15.5	14.6	8.0	9.5	9.4	6.6	10.3	10.0	23.8	47.7	44.6	42.4	30.5	24.5	18.7	38.2	10.7	17.0	45.4	23.6	52.4	8.3	82.1	0.8	27.6	80.5	0.0	51.5	49.0	63.2	112.7	66.9	21.3	139.8	9.5	108.9	26.4	42.3	0.7	25.6	53.4	67.4	25.2	37.4	48.4	45.4	80.7	21.9	55.3	29.8	25.8	42.2	5.0	7.5	36.4	164.8	28.7	38.6	31.8
NEU2	SIAL2	ENSG00000115488	"Neuraminidase 2"	Q9Y3R4	2	233032672-233035057	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"skin 1: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 1.1;BEWO: 1.6;PC-3: 3.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.2;hippocampal formation: 1.1"	CAB022336	Uncertain					NA	NA		9000			"CAB022336: "						"unprognostic (1.30e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988134-75018893	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 58.9;Spermatocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	5.4	13.4	3.7	10.5	6.9	17.0	5.4	7.9	9.1	4.0	3.9	3.0	4.1	3.6	5.4	4.8	3.9	4.4	3.6	5.9	4.0	4.5	4.3	6.7	8.7	9.0	3.8	6.6	7.2	7.3	15.1	11.2	3.1	4.2	9.7	5.4	5.6	4.8	4.6	19.1	6.7	4.7	4.0	3.5	5.5	5.1	44.6	3.0	19.0	6.8	3.5	7.5	4.5	3.1	3.2	3.8	5.8	6.4	1.2	4.2	2.2	4.6	4.0	3.4	6.6	2.6	2.5	3.8	4.5	2.9	5.2	4.0	13.7	3.9	13.3	4.6	3.6	6.6	4.3	8.2	5.8	7.9	7.0	4.4	10.9	7.4	5.6	2.9	17.2	10.6	3.0	4.9	5.2	8.1	3.4	3.7	19.0	17.7	10.0	5.9	5.0	16.9	8.9	4.2	9.1	5.4	14.8	9.0	11.7	6.4	4.9	6.3	4.0	6.9	4.6	20.2	4.2	9.8	4.4	5.6	6.5	6.5	4.3	4.5	8.2	8.0	26.6	1.9	8.9	5.5	2.1	6.4	5.8	4.1	3.7	3.0	2.8	3.2	3.9	3.8	3.2	3.5	4.2	3.3	1.2	4.6	2.7	2.3	2.2	3.7	6.9	7.9	9.1	4.0	4.5	3.8	6.6	4.2	3.0	3.0	5.8	2.2	1.8	0.5	7.2	7.3	2.5	2.7	4.5	1.8	58.9	1.8	0.0	1.0	5.7	1.6	1.3	0.0	2.6	1.2	1.5	2.7	1.1	7.2	4.8	11.1	6.9	4.3	8.6	5.3	1.4	4.5	0.0	4.6	2.9	2.9	2.7	0.0	1.8	3.3	5.8	0.0	2.2	32.5	1.7	0.5	1.1	3.5	3.2	0.4
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241808825-241817413	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 27.1;liver: 42.9"	"Cell type enhanced"	"Detected in some"	14	"Enterocytes: 65.6;Hepatocytes: 117.5;Intestinal endocrine cells: 33.1;Mucus-secreting cells: 40.3;Paneth cells: 66.2;Undifferentiated cells: 40.1"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"Hep G2: 22.5;HMC-1: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037394	Enhanced					NA	NA					"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.6	0.5	6.5	0.7	5.3	5.7	0.3	1.9	7.0	0.6	13.9	4.9	0.0	9.3	0.3	0.3	0.7	1.1	2.6	0.6	6.4	5.8	1.4	42.9	0.4	0.5	6.9	4.4	0.4	0.3	0.3	0.4	0.4	3.8	0.5	6.1	0.0	0.4	0.4	3.6	0.3	27.1	0.4	4.1	0.5	0.5	0.6	2.3	0.0	0.4	2.8	0.3	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.5	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	5.3	1.9	4.0	6.4	5.8	6.9	4.4	3.8	2.3	0.0	0.0	0.9	0.0	0.0	0.7	0.5	0.0	0.0	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.0	65.6	0.0	0.0	0.0	0.2	0.0	1.1	117.5	1.2	0.0	33.1	0.6	3.2	0.0	0.6	0.7	0.0	0.0	40.3	26.2	0.0	66.2	0.7	8.6	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	40.1	0.1
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619970-128681075	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		8200000	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	52.3	37.5	22.2	26.6	23.8	24.4	48.2	20.9	31.4	45.8	40.8	31.9	58.8	28.5	38.3	110.2	32.2	38.3	38.8	47.1	23.0	28.0	55.4	174.0	47.4	50.6	26.4	18.3	37.8	62.9	43.5	36.9	58.3	24.3	31.4	41.1	28.6	54.1	55.5	34.4	24.0	37.0	33.5	31.8	48.0	33.7	26.9	23.3	34.3	69.1	27.3	36.5	32.7	39.7	26.7	53.1	64.4	43.5	23.4	45.1	53.3	60.5	33.0	27.6	50.7	74.7	50.1	62.5	52.2	68.7	69.4	80.9	68.4	57.1	37.9	49.3	75.3	64.7	61.0	44.5	46.5	68.0	27.2	28.6	66.8	24.6	56.2	82.4	54.2	35.2	41.5	54.4	45.6	67.5	46.5	54.2	28.7	27.5	50.9	45.5	55.4	30.0	59.6	35.0	81.1	30.3	32.9	37.1	91.2	48.1	36.4	42.5	24.5	42.9	44.5	52.8	36.9	47.6	56.1	35.2	35.9	28.1	52.5	38.7	54.9	43.2	40.5	58.9	40.4	51.8	38.8	43.5	35.7	37.3	40.0	45.1	26.7	30.7	33.8	43.5	18.3	19.1	29.2	64.4	23.4	40.2	53.1	30.5	53.3	22.2	23.8	20.9	31.4	23.0	28.0	26.4	18.3	24.3	23.3	56.6	71.5	37.3	71.3	44.0	11.5	35.3	61.1	66.9	47.8	106.4	7.9	108.3	13.3	99.9	13.7	58.2	107.9	46.7	81.2	161.1	79.3	88.0	42.7	155.3	122.7	19.1	41.6	107.4	134.1	20.7	87.2	73.4	55.6	36.9	102.4	27.5	98.9	83.4	60.5	80.2	11.7	45.3	39.6	49.9	59.8	46.7	131.0	50.0	106.2	66.4
RPN2	"RIBIIR, RPN-II, RPNII, SWP1"	ENSG00000118705	"Ribophorin II"	P04844	20	37178410-37241623	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 520.7;Syncytiotrophoblasts: 519.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008297, CAB019277, HPA025922"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		2800000	"Endoplasmic reticulum"		"CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458"	"unprognostic (9.59e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.44e-10)"	"unprognostic (2.83e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.44e-4)"	29.2	47.6	16.6	24.2	19.6	30.1	34.8	13.2	21.4	34.3	30.5	23.3	52.6	24.0	38.3	70.3	35.1	29.5	34.8	36.3	14.2	14.1	52.9	105.7	38.7	53.0	19.1	14.7	33.3	72.2	38.2	28.7	110.3	19.8	33.3	34.7	43.1	64.6	49.1	32.9	26.0	43.2	30.2	15.6	47.5	35.7	43.5	14.5	27.9	56.8	26.4	42.3	27.8	27.7	48.1	96.3	55.8	70.1	60.8	72.3	92.9	36.7	33.2	34.8	46.3	48.4	36.3	69.1	48.7	57.9	62.4	53.1	105.4	64.5	28.8	59.6	62.7	58.2	53.6	36.0	57.9	56.9	13.4	22.3	32.9	38.8	70.2	46.8	51.9	55.2	34.2	57.9	49.5	51.5	59.7	59.8	27.0	50.4	93.9	43.7	33.2	29.8	53.0	28.1	93.3	47.2	27.2	64.6	94.4	42.8	35.0	28.8	30.8	59.0	142.5	56.6	42.6	70.4	87.3	38.6	70.9	43.2	36.9	42.2	56.5	67.4	30.3	69.5	35.2	57.2	55.8	70.1	45.1	62.8	66.6	72.3	48.1	59.2	62.8	78.7	37.4	53.8	55.5	13.0	60.8	53.7	96.3	52.9	92.9	16.6	19.6	13.2	21.4	14.2	14.1	19.1	14.7	19.8	14.5	110.2	155.8	75.4	110.3	55.0	62.6	70.6	129.9	77.6	87.6	76.8	43.2	403.6	19.9	222.8	23.6	87.5	73.5	93.5	212.6	520.7	89.4	118.5	102.7	173.2	208.9	60.4	60.5	106.8	138.1	22.0	97.2	119.0	86.0	115.4	110.0	140.5	151.9	100.8	104.3	52.6	62.7	84.1	70.1	327.7	305.6	50.6	519.4	74.0	130.8	106.2
ST6GAL1	SIAT1	ENSG00000073849	"ST6 beta-galactoside alpha-2,6-sialyltransferase 1"	P15907	3	186930485-187078553	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.4"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 225.1;Hepatocytes: 512.9;Ito cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.6;U-266/70: 104.1;U-266/84: 133.1;U-698: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015018, CAB016122"	Supported				"Secreted to blood"	NA	NA	15000000	580000			"CAB015018: AB_629203, CAB016122: AB_627178"	"unprognostic (5.85e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-2)"	10.6	6.5	11.8	16.7	15.4	4.0	10.5	2.8	11.8	19.1	11.4	22.7	4.2	4.3	8.6	4.3	4.4	8.6	5.7	10.6	10.7	7.6	19.1	161.4	10.9	27.6	18.2	7.6	4.5	4.1	20.5	5.7	5.5	13.7	19.5	14.2	5.4	17.7	4.6	5.7	4.5	12.6	5.8	22.3	27.0	8.5	2.4	15.1	19.4	19.4	4.0	41.6	13.2	14.3	33.6	4.6	6.9	8.9	8.5	29.3	16.9	0.7	0.7	3.1	2.3	0.2	0.0	4.8	0.2	0.4	0.1	0.3	0.2	0.2	32.6	2.7	0.0	1.2	1.4	19.2	2.0	0.2	1.6	0.8	1.3	0.1	15.9	0.1	3.0	10.3	0.2	4.1	0.0	1.8	2.8	11.3	3.3	6.6	3.1	1.0	1.4	2.2	2.1	6.9	1.6	1.0	5.3	0.0	1.0	1.4	0.0	5.0	0.5	0.2	3.7	8.5	4.7	5.4	2.2	4.3	0.0	0.4	0.0	0.3	104.1	133.1	48.5	0.1	6.1	11.3	6.9	2.7	1.1	16.5	5.2	15.0	32.7	18.2	13.8	4.6	33.6	29.3	20.2	1.3	8.5	8.9	4.2	14.2	16.9	11.8	15.4	2.8	11.8	10.7	7.6	18.2	7.6	13.7	15.1	41.7	20.6	118.9	14.7	3.5	0.0	22.2	86.6	24.1	44.3	225.1	0.0	0.3	0.0	14.5	0.3	29.9	4.1	23.3	0.8	3.1	1.9	58.6	10.4	512.9	16.4	0.0	90.6	264.6	52.6	0.7	0.3	13.4	6.8	5.4	3.3	0.0	6.7	5.8	0.7	0.5	1.1	0.0	5.1	0.0	0.2	1.4	0.6	20.0	28.1	28.2
ST6GAL2	"KIAA1877, SIAT2, St6gal2, St6GalII"	ENSG00000144057	"ST6 beta-galactoside alpha-2,6-sialyltransferase 2"	Q96JF0	2	106801600-106887108	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;thyroid gland: 34.0"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 7.7;Ito cells: 2.5;Mucus-secreting cells: 2.3"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;hTERT-RPE1: 7.2;NTERA-2: 4.9;PC-3: 6.4;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014459	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA014459: AB_1857528"	"unprognostic (2.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.56e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.01e-4)"	"unprognostic (4.70e-4)"	"unprognostic (4.06e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.07e-2)"	1.2	0.7	14.1	0.7	5.6	1.5	1.3	2.3	16.7	2.1	1.5	4.1	1.7	0.7	3.7	1.9	2.7	1.2	12.7	1.9	5.4	4.0	1.1	3.4	1.2	0.9	3.8	7.1	0.9	0.5	0.5	0.3	2.3	4.2	1.6	3.3	0.0	1.6	1.6	0.7	1.3	0.7	2.8	1.9	0.6	0.9	7.9	1.5	0.0	34.0	1.6	0.8	1.5	1.4	0.7	0.6	1.8	0.5	1.0	0.7	0.5	0.0	5.7	3.1	0.1	0.0	0.0	0.1	0.3	0.0	1.3	0.4	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	7.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.9	0.0	6.4	0.0	0.0	10.2	0.2	0.0	6.8	4.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	8.3	0.1	0.2	0.0	10.9	0.2	0.1	0.0	0.0	0.0	1.4	0.5	0.4	0.6	0.3	0.5	0.4	0.4	0.5	0.2	0.7	0.5	0.7	1.8	1.0	0.3	0.6	0.5	0.5	14.1	5.6	2.3	14.8	5.4	4.0	3.8	7.1	4.2	1.5	0.0	0.0	0.0	0.1	0.8	7.7	1.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.2	0.0	1.2	2.5	0.0	0.0	0.3	0.0	0.0	0.0	2.3	0.8	0.0	0.0	0.7	0.6	0.5	0.0	1.4	0.0	1.3	0.0	0.2	0.0	1.2	0.0
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3A, catalytic subunit of the oligosaccharyltransferase complex"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 202.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	20.6	20.5	8.3	13.1	11.7	8.3	16.9	10.7	13.9	27.8	19.3	17.7	39.6	12.0	30.5	41.4	19.6	20.8	15.1	19.5	8.3	9.1	26.2	67.1	18.7	14.9	9.3	7.7	30.1	59.0	202.3	27.5	35.9	11.6	22.2	17.4	20.8	50.7	41.4	9.5	12.9	19.8	17.1	12.3	21.8	17.7	17.1	6.7	19.2	38.6	13.6	20.8	19.5	18.0	15.0	53.2	27.0	15.5	17.2	27.5	13.4	21.0	19.2	24.5	33.6	46.2	35.8	26.3	38.5	46.0	31.3	39.2	58.2	56.9	27.4	46.7	56.6	44.4	38.9	33.9	33.7	41.7	21.3	18.0	64.5	13.2	40.2	51.1	38.6	30.3	27.6	24.5	43.4	84.8	36.9	34.9	12.3	27.1	41.1	39.5	15.5	15.5	12.3	15.7	42.1	20.9	18.4	20.9	41.2	34.2	32.7	15.2	13.2	27.2	44.5	13.7	30.0	52.2	27.8	31.2	45.2	16.3	19.0	30.2	12.9	15.1	21.1	17.4	39.1	35.8	27.0	15.5	11.6	19.7	14.8	27.5	15.0	19.1	18.2	21.6	11.6	13.8	16.0	5.4	17.2	13.0	53.2	14.1	13.4	8.3	11.7	10.7	13.9	8.3	9.1	9.3	7.7	11.6	6.7	26.8	23.5	18.2	11.3	14.3	10.2	18.6	12.7	14.7	14.8	15.7	19.6	40.7	1.7	26.7	7.6	11.9	13.5	23.3	23.5	56.2	25.7	16.7	16.2	32.7	27.0	1.6	15.0	33.2	22.3	2.6	19.8	13.2	23.6	8.2	32.3	15.2	29.5	14.0	17.7	11.9	13.8	19.4	10.3	29.9	10.9	12.9	38.1	13.3	22.9	12.9
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3B, catalytic subunit of the oligosaccharyltransferase complex"	Q8TCJ2	3	31532638-31637622	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		9300	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	23.0	30.3	16.0	27.5	16.7	21.7	27.4	15.4	19.4	28.4	25.0	16.9	37.0	18.6	28.4	37.9	28.8	22.4	29.0	27.5	15.1	15.6	28.2	64.1	30.1	36.9	16.5	15.5	62.3	39.4	36.2	20.3	85.9	16.5	26.3	25.1	22.3	25.2	26.3	31.2	19.2	29.2	23.2	19.7	29.4	22.9	36.7	13.6	60.2	44.3	23.4	30.3	27.5	27.7	3.6	7.7	8.4	5.3	8.4	8.5	3.0	16.6	28.0	25.8	27.0	32.5	32.8	56.4	31.3	27.5	23.4	27.2	25.5	36.2	29.0	15.4	28.3	19.3	14.1	23.8	27.1	30.8	81.6	15.7	24.8	28.5	27.1	25.1	53.5	29.7	25.1	29.1	33.3	42.2	36.2	23.6	37.2	13.3	46.5	31.8	9.4	52.3	33.1	20.8	27.9	15.8	54.7	14.0	42.0	27.2	24.1	11.0	13.4	31.0	46.1	18.1	23.0	20.7	28.6	45.9	31.7	20.3	31.3	27.5	29.3	35.1	24.3	28.7	36.8	26.0	2.3	4.6	8.4	4.7	5.3	7.5	3.4	8.5	6.5	4.0	3.6	8.2	6.5	1.7	8.4	3.7	7.7	4.1	3.0	16.0	16.7	15.4	19.4	15.1	15.6	16.5	15.5	16.5	13.6	80.4	51.9	42.7	51.5	60.6	48.3	64.1	56.0	40.2	88.7	41.8	64.8	58.7	11.6	32.8	125.1	35.0	40.6	0.0	38.9	84.1	47.2	61.2	31.1	58.2	50.2	42.9	43.4	38.6	46.8	186.1	33.6	58.1	49.0	9.0	50.8	36.3	38.5	49.1	30.8	26.4	33.6	25.8	38.9	61.2	52.7	54.1	79.8	62.1	51.2	55.9
TUSC3	"MGC13453, MRT7, N33, OST3A"	ENSG00000104723	"Tumor suppressor candidate 3"	Q13454	8	15417215-15766649	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 127.8"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 406.6;Extravillous trophoblasts: 249.7;Syncytiotrophoblasts: 655.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049851, HPA049974"	Approved					NA	NA					"HPA049851: AB_2680913, HPA049974: AB_2680976"	"unprognostic (3.31e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.81e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.86e-4)"	"unprognostic (1.55e-1)"	10.5	35.3	10.5	4.0	23.0	0.1	19.7	21.5	19.8	12.1	6.2	5.4	5.1	4.5	16.0	50.5	6.1	27.0	8.1	16.1	10.4	21.4	11.6	3.2	8.5	3.3	6.0	15.6	35.5	15.8	24.8	50.6	127.8	13.4	23.9	7.1	11.6	5.7	14.1	2.8	3.8	4.1	14.4	4.3	3.6	5.2	10.2	3.3	2.9	4.7	3.6	2.4	15.0	9.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	13.2	9.6	26.5	24.7	30.9	35.8	0.0	18.8	40.4	20.8	34.9	0.0	0.0	0.1	6.6	25.0	23.0	10.1	9.2	18.0	30.3	0.0	12.6	0.0	7.8	1.5	13.4	0.0	1.3	28.4	5.7	29.1	10.9	29.9	1.7	3.9	17.5	4.0	31.6	9.5	4.8	0.1	13.2	0.0	8.3	5.9	22.0	0.1	28.8	33.0	10.5	20.3	0.0	10.7	14.6	20.2	12.6	0.0	8.1	19.2	19.0	8.0	9.3	0.0	2.3	0.0	0.3	0.0	26.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.5	23.0	21.5	19.8	10.4	21.4	6.0	15.6	13.4	3.3	0.0	9.3	0.0	50.9	8.9	49.5	42.5	20.4	75.0	29.6	75.0	7.9	406.6	14.9	137.4	9.6	16.8	0.2	0.0	10.2	249.7	45.2	77.9	1.1	0.0	36.4	30.2	92.1	10.4	0.0	5.7	32.2	2.2	23.6	2.8	20.2	33.8	32.0	0.0	21.5	18.8	20.0	38.8	18.3	50.1	42.8	3.6	655.5	0.5	8.3	40.9
